| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.984 | 0.002 | 0.984 | Antiadrenergic | |||
| 0.983 | 0.002 | 0.983 | Adrenaline antagonist | |||
| 0.853 | 0.001 | 0.853 | Alpha 2b adrenoreceptor agonist | 0.024 0.007 DBMET02113 | ||
| 0.782 | 0.003 | 0.782 | Alpha adrenoreceptor agonist | |||
| 0.746 | 0.003 | 0.746 | Alpha 2b adrenoreceptor antagonist | 0.095 0.079 DBMET02113 | ||
| 0.738 | 0.002 | 0.738 | Alpha 2 adrenoreceptor agonist | 0.068 0.034 DBMET02113 | ||
| 0.736 | 0.003 | 0.736 | 5 Hydroxytryptamine 1A agonist | |||
| 0.71 | 0.001 | 0.71 | Alpha 2c adrenoreceptor agonist | 0.017 0.016 DBMET02113 | ||
| 0.666 | 0.003 | 0.666 | Alpha 2a adrenoreceptor antagonist | |||
| 0.659 | 0.001 | 0.659 | Alpha 2a adrenoreceptor agonist | 0.047 0.004 DBMET02113 | ||
| 0.618 | 0.003 | 0.618 | Alpha 2c adrenoreceptor antagonist | |||
| 0.597 | 0.004 | 0.597 | Alpha 2 adrenoreceptor antagonist | |||
| 0.594 | 0.001 | 0.594 | Imidazoline I1 receptor antagonist | 0.02 0.016 DBMET02113 | ||
| 0.597 | 0.027 | 0.597 | Analgesic | |||
| 0.568 | 0.005 | 0.568 | Alpha adrenoreceptor antagonist | |||
| 0.513 | 0.004 | 0.513 | 5 Hydroxytryptamine 1 agonist | |||
| 0.508 | 0.005 | 0.508 | 5 Hydroxytryptamine agonist | |||
| 0.485 | 0.001 | 0.485 | Alpha 1b adrenoreceptor agonist | |||
| 0.465 | 0.003 | 0.465 | Alpha 1 adrenoreceptor agonist | |||
| 0.431 | 0.001 | 0.431 | Alpha 1a adrenoreceptor agonist | |||
| 0.4 | 0.001 | 0.4 | Imidazoline I2 receptor antagonist | |||
| 0.394 | 0.001 | 0.394 | Alpha 2d adrenoreceptor agonist | |||
| 0.384 | 0.001 | 0.384 | Alpha 2d adrenoreceptor antagonist | |||
| 0.357 | 0 | 0.357 | Alpha 1L adrenoreceptor agonist | |||
| 0.385 | 0.03 | 0.425 | Calcium channel activator | 0.257 0.138 DBMET02111 0.425 0.017 DBMET02113 0.378 0.034 DBMET02112 | DBMET02113 | |
| 0.334 | 0.003 | 0.334 | Adrenaline agonist | 0.074 0.066 DBMET02111 0.108 0.032 DBMET02113 0.106 0.033 DBMET02112 | ||
| 0.393 | 0.064 | 0.647 | GABA C receptor rho-3 antagonist | 0.306 0.112 DBMET02111 0.647 0.004 DBMET02113 0.417 0.054 DBMET02112 | DBMET02113 | |
| 0.36 | 0.035 | 0.603 | Hypoglycemic | 0.603 0.008 DBMET02112 | DBMET02112 | |
| 0.321 | 0.019 | 0.321 | Diuretic | 0.212 0.04 DBMET02111 0.231 0.034 DBMET02113 0.216 0.039 DBMET02112 | ||
| 0.385 | 0.091 | 0.385 | Calcium channel L-type activator | 0.284 0.171 DBMET02113 | ||
| 0.298 | 0.011 | 0.298 | Alpha 1 adrenoreceptor antagonist | |||
| 0.287 | 0.014 | 0.287 | Insulin secretagoues | 0.194 0.039 DBMET02112 | ||
| 0.248 | 0.025 | 0.248 | 5 Hydroxytryptamine antagonist | |||
| 0.279 | 0.057 | 0.561 | 5 Hydroxytryptamine uptake stimulant | 0.315 0.038 DBMET02111 0.561 0.003 DBMET02113 0.435 0.009 DBMET02112 | DBMET02113 | |
| 0.231 | 0.012 | 0.231 | Alpha 1b adrenoreceptor antagonist | |||
| 0.247 | 0.028 | 0.247 | MAO inhibitor | 0.133 0.068 DBMET02113 | ||
| 0.336 | 0.133 | 0.828 | Cyclophilin D inhibitor | 0.828 0.005 DBMET02112 | DBMET02112 | |
| 0.21 | 0.009 | 0.21 | Alpha 1d adrenoreceptor antagonist | |||
| 0.214 | 0.015 | 0.214 | Alpha 1a adrenoreceptor antagonist | |||
| 0.292 | 0.101 | 0.411 | Vasodilator, peripheral | 0.282 0.106 DBMET02113 0.411 0.052 DBMET02112 | DBMET02112 | |
| 0.244 | 0.07 | 0.244 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.19 | 0.026 | 0.19 | MAO B inhibitor | 0.112 0.054 DBMET02113 | ||
| 0.182 | 0.019 | 0.182 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.172 | 0.009 | 0.172 | Toll-Like receptor 3 antagonist | |||
| 0.191 | 0.033 | 0.191 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.17 | 0.018 | 0.17 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.275 | 0.135 | 0.544 | Antiobesity | 0.544 0.029 DBMET02112 | DBMET02112 | |
| 0.211 | 0.072 | 0.33 | Nitric-oxide synthase stimulant | 0.239 0.04 DBMET02111 0.33 0.006 DBMET02113 0.275 0.019 DBMET02112 | DBMET02113 | |
| 0.137 | 0.011 | 0.137 | Adrenaline uptake inhibitor | |||
| 0.126 | 0.002 | 0.126 | Parathyroid hormone antagonist | 0.056 0.014 DBMET02111 | ||
| 0.13 | 0.008 | 0.13 | Beta adrenoreceptor antagonist | 0.062 0.052 DBMET02111 0.073 0.034 DBMET02113 0.085 0.024 DBMET02112 | ||
| 0.313 | 0.196 | 0.449 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.291 0.224 DBMET02111 0.449 0.062 DBMET02113 0.296 0.218 DBMET02112 | DBMET02113 | |
| 0.135 | 0.018 | 0.165 | Lanosterol 14 alpha demethylase inhibitor | 0.165 0.008 DBMET02113 0.123 0.027 DBMET02112 | DBMET02113 | |
| 0.131 | 0.016 | 0.223 | Glutamate release inhibitor | 0.119 0.023 DBMET02111 0.223 0.004 DBMET02113 0.189 0.005 DBMET02112 | DBMET02113 | |
| 0.118 | 0.004 | 0.118 | Kallikrein 7 inhibitor | |||
| 0.121 | 0.007 | 0.121 | Beta 1 adrenoreceptor antagonist | 0.062 0.034 DBMET02113 0.071 0.025 DBMET02112 | ||
| 0.201 | 0.09 | 0.201 | HERG channel blocker | |||
| 0.288 | 0.179 | 0.561 | 5 Hydroxytryptamine release inhibitor | 0.472 0.042 DBMET02111 0.561 0.017 DBMET02113 0.543 0.021 DBMET02112 | DBMET02113 | |
| 0.156 | 0.048 | 0.156 | Nav1.6 sodium channel blocker | 0.147 0.057 DBMET02113 | ||
| 0.12 | 0.02 | 0.12 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.14 | 0.042 | 0.286 | Ferrochelatase inhibitor | 0.286 0.009 DBMET02113 0.278 0.01 DBMET02112 | DBMET02113 | |
| 0.098 | 0.004 | 0.098 | Alpha 1d adrenoreceptor agonist | 0.066 0.008 DBMET02113 | ||
| 0.102 | 0.009 | 0.102 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.11 | 0.024 | 0.142 | Glycine receptor antagonist | 0.142 0.009 DBMET02113 0.094 0.038 DBMET02112 | DBMET02113 | |
| 0.291 | 0.204 | 0.499 | Caspase 9 stimulant | 0.499 0.06 DBMET02113 0.366 0.133 DBMET02112 | DBMET02113 | |
| 0.146 | 0.06 | 0.189 | Nav1.2 sodium channel blocker | 0.189 0.038 DBMET02111 0.135 0.068 DBMET02113 | DBMET02111 | |
| 0.187 | 0.101 | 0.187 | Potassium channel blocker | |||
| 0.093 | 0.011 | 0.093 | 5 Hydroxytryptamine 2 agonist | 0.059 0.028 DBMET02113 | ||
| 0.201 | 0.12 | 0.625 | 5 Hydroxytryptamine release stimulant | 0.435 0.039 DBMET02111 0.625 0.012 DBMET02113 0.482 0.03 DBMET02112 | DBMET02113 | |
| 0.118 | 0.037 | 0.118 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.091 | 0.019 | 0.092 | 5 Hydroxytryptamine 2A agonist | 0.092 0.018 DBMET02113 0.063 0.044 DBMET02112 | DBMET02113 | |
| 0.2 | 0.131 | 0.294 | 5 Hydroxytryptamine 1E antagonist | 0.294 0.033 DBMET02113 | DBMET02113 | |
| 0.158 | 0.098 | 0.488 | Succinate dehydrogenase inhibitor | 0.202 0.047 DBMET02111 0.488 0.003 DBMET02113 0.458 0.003 DBMET02112 | DBMET02113 | |
| 0.126 | 0.067 | 0.133 | Nav1.3 sodium channel blocker | 0.133 0.061 DBMET02111 0.129 0.065 DBMET02113 | DBMET02111 | |
| 0.088 | 0.03 | 0.21 | I kappa B kinase 1 inhibitor | 0.21 0.005 DBMET02111 0.082 0.035 DBMET02112 | DBMET02111 | |
| 0.081 | 0.024 | 0.124 | Exportin-1 inhibitor | 0.107 0.006 DBMET02111 0.109 0.006 DBMET02113 0.124 0.004 DBMET02112 | DBMET02112 | |
| 0.064 | 0.007 | 0.064 | 5 Hydroxytryptamine 2B agonist | 0.053 0.011 DBMET02113 0.038 0.029 DBMET02112 | ||
| 0.096 | 0.049 | 0.424 | NADH dehydrogenase inhibitor | 0.089 0.058 DBMET02111 0.424 0.004 DBMET02113 0.243 0.008 DBMET02112 | DBMET02113 | |
| 0.067 | 0.025 | 0.073 | Beta 2 adrenoreceptor agonist | 0.061 0.047 DBMET02111 0.073 0.015 DBMET02113 | DBMET02113 | |
| 0.118 | 0.077 | 0.118 | Glutamate receptor antagonist | 0.109 0.086 DBMET02113 | ||
| 0.138 | 0.098 | 0.138 | Polo-like kinase-3 inhibitor | |||
| 0.103 | 0.063 | 0.103 | Nav1.1 sodium channel blocker | |||
| 0.128 | 0.093 | 0.703 | Peroxidase inhibitor | 0.263 0.045 DBMET02111 0.703 0.003 DBMET02113 0.505 0.009 DBMET02112 | DBMET02113 | |
| 0.042 | 0.009 | 0.171 | Kynurenine 3 monooxygenase inhibitor | 0.069 0.005 DBMET02113 0.171 0.003 DBMET02112 | DBMET02112 | |
| 0.17 | 0.137 | 0.233 | 5 Hydroxytryptamine 3E antagonist | 0.188 0.086 DBMET02111 0.233 0.025 DBMET02113 | DBMET02113 | |
| 0.133 | 0.1 | 0.266 | GABA C receptor rho-2 antagonist | 0.266 0.009 DBMET02113 0.154 0.068 DBMET02112 | DBMET02113 | |
| 0.053 | 0.023 | 0.148 | NMDA receptor subunit 3B antagonist | 0.148 0.006 DBMET02113 0.046 0.028 DBMET02112 | DBMET02113 | |
| 0.133 | 0.103 | 0.193 | Ca2+-transporting ATPase inhibitor | 0.193 0.004 DBMET02113 0.171 0.012 DBMET02112 | DBMET02113 | |
| 0.042 | 0.017 | 0.064 | Prostacyclin antagonist | 0.064 0.008 DBMET02112 | DBMET02112 | |
| 0.054 | 0.03 | 0.054 | Beta 2 adrenoreceptor antagonist | 0.053 0.032 DBMET02113 | ||
| 0.186 | 0.163 | 0.42 | Tyrosine 3 hydroxylase inhibitor | 0.261 0.058 DBMET02111 0.42 0.006 DBMET02113 0.308 0.03 DBMET02112 | DBMET02113 | |
| 0.058 | 0.039 | 0.058 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.079 | 0.06 | 0.079 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.067 | 0.048 | 0.067 | Neuronal nicotinic receptor antagonist | |||
| 0.074 | 0.062 | 0.074 | Acetylcholine nicotinic antagonist | |||
| 0.078 | 0.068 | 0.145 | NMDA receptor antagonist | 0.145 0.026 DBMET02113 0.094 0.051 DBMET02112 | DBMET02113 | |
| 0.055 | 0.045 | 0.12 | Pregnane X receptor antagonist | 0.12 0.003 DBMET02113 0.072 0.012 DBMET02112 | DBMET02113 | |
| 0.089 | 0.08 | 0.156 | Urease inhibitor | 0.09 0.079 DBMET02111 0.156 0.02 DBMET02113 0.1 0.066 DBMET02112 | DBMET02113 | |
| 0.036 | 0.028 | 0.11 | NMDA receptor subunit 3A antagonist | 0.11 0.008 DBMET02113 0.033 0.031 DBMET02112 | DBMET02113 | |
| 0.05 | 0.043 | 0.05 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.074 | 0.068 | 0.074 | ALK inhibitor | |||
| 0.043 | 0.04 | 0.051 | Beta adrenoreceptor agonist | 0.044 0.036 DBMET02111 0.048 0.021 DBMET02113 0.051 0.016 DBMET02112 | DBMET02112 | |
| 0.059 | 0.059 | 0.082 | Beta 3 adrenoreceptor antagonist | 0.078 0.025 DBMET02113 0.082 0.022 DBMET02112 | DBMET02112 | |
| 0.081 | 0.088 | 0.38 | UDP-glucose 4-epimerase inhibitor | 0.101 0.059 DBMET02111 0.38 0.007 DBMET02113 0.248 0.013 DBMET02112 | DBMET02113 | |
| 0.14 | 0.149 | 0.753 | Aldehyde oxidase inhibitor | 0.275 0.073 DBMET02111 0.753 0.005 DBMET02113 0.717 0.007 DBMET02112 | DBMET02113 | |
| 0.024 | 0.034 | 0.044 | Lysophosphatidic acid 2 receptor antagonist | 0.044 0.01 DBMET02113 0.044 0.01 DBMET02112 | DBMET02112 | |
| 0.086 | 0.097 | 0.193 | Adenylate kinase inhibitor | 0.11 0.053 DBMET02111 0.182 0.018 DBMET02113 0.193 0.016 DBMET02112 | DBMET02112 | |
| 0.025 | 0.036 | 0.053 | Renin inhibitor | 0.053 0.016 DBMET02111 0.031 0.03 DBMET02112 | DBMET02111 | |
| 0.15 | 0.165 | 0.185 | Spasmolytic | 0.185 0.133 DBMET02113 | DBMET02113 | |
| 0.092 | 0.107 | 0.128 | Acetylcholine release stimulant | 0.102 0.084 DBMET02111 0.128 0.037 DBMET02113 0.103 0.08 DBMET02112 | DBMET02113 | |
| 0.042 | 0.061 | 0.066 | Dopamine uptake inhibitor | 0.066 0.033 DBMET02113 | DBMET02113 | |
| 0.029 | 0.049 | 0.048 | Tryptophan 5 hydroxylase inhibitor | 0.044 0.009 DBMET02113 0.048 0.006 DBMET02112 | DBMET02112 | |
| 0.066 | 0.086 | 0.135 | Histamine N-methyltransferase inhibitor | 0.135 0.02 DBMET02113 | DBMET02113 | |
| 0.082 | 0.102 | 0.227 | 5 Hydroxytryptamine 3A agonist | 0.227 0.009 DBMET02113 | DBMET02113 | |
| 0.093 | 0.115 | 0.201 | Cyclooxygenase 3 inhibitor | 0.156 0.043 DBMET02111 0.201 0.018 DBMET02113 0.195 0.02 DBMET02112 | DBMET02113 | |
| 0.027 | 0.05 | 0.049 | Protein kinase (CK2) beta inhibitor | 0.049 0.007 DBMET02113 | DBMET02113 | |
| 0.027 | 0.05 | 0.054 | Ceramide glucosyltransferase inhibitor | 0.054 0.005 DBMET02113 | DBMET02113 | |
| 0.143 | 0.167 | 0.235 | Vasodilator | 0.235 0.078 DBMET02112 | DBMET02112 | |
| 0.091 | 0.115 | 0.497 | Alpha-N-acetylglucosaminidase inhibitor | 0.143 0.059 DBMET02111 0.418 0.008 DBMET02113 0.497 0.005 DBMET02112 | DBMET02112 | |
| 0.105 | 0.131 | 0.118 | Acetylcholine M1 receptor antagonist | 0.118 0.111 DBMET02113 | DBMET02113 | |
| 0.019 | 0.05 | 0.035 | Potassium channel small-conductance Ca-activated activator | 0.035 0.018 DBMET02113 | DBMET02113 | |
| 0.019 | 0.052 | 0.033 | Thymidine phosphorylase inhibitor | 0.033 0.009 DBMET02113 | DBMET02113 | |
| 0.037 | 0.07 | 0.095 | Dopamine beta hydroxylase inhibitor | 0.095 0.004 DBMET02113 | DBMET02113 | |
| 0.015 | 0.048 | 0.031 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.031 0.004 DBMET02113 0.02 0.018 DBMET02112 | DBMET02113 | |
| 0.044 | 0.078 | 0.163 | Dopamine D1 antagonist | 0.163 0.013 DBMET02113 | DBMET02113 | |
| 0.026 | 0.061 | 0.131 | Dopamine D5 agonist | 0.131 0.003 DBMET02113 | DBMET02113 | |
| 0.019 | 0.056 | 0.04 | Purinergic P2Y15 antagonist | 0.039 0.007 DBMET02111 0.04 0.007 DBMET02113 | DBMET02113 | |
| 0.054 | 0.093 | 0.111 | Phospholipase D inhibitor | 0.111 0.009 DBMET02113 0.071 0.052 DBMET02112 | DBMET02113 | |
| 0.02 | 0.059 | 0.088 | Farnesoid X receptor agonist | 0.052 0.014 DBMET02113 0.088 0.005 DBMET02112 | DBMET02112 | |
| 0.126 | 0.166 | 0.284 | Phospholipase C inhibitor | 0.175 0.066 DBMET02111 0.284 0.02 DBMET02113 0.203 0.042 DBMET02112 | DBMET02113 | |
| 0.113 | 0.155 | 0.269 | Psychostimulant | 0.269 0.052 DBMET02111 0.212 0.074 DBMET02113 0.193 0.084 DBMET02112 | DBMET02111 | |
| 0.019 | 0.062 | 0.086 | Phosphoglycerate kinase inhibitor | 0.045 0.016 DBMET02111 0.086 0.008 DBMET02113 0.077 0.009 DBMET02112 | DBMET02113 | |
| 0.052 | 0.097 | 0.087 | Nicotinic alpha4beta2 receptor antagonist | 0.087 0.043 DBMET02113 | DBMET02113 | |
| 0.064 | 0.11 | 0.269 | HIV-1 integrase (Overall Integration) inhibitor | 0.269 0.004 DBMET02113 0.178 0.017 DBMET02112 | DBMET02113 | |
| 0.054 | 0.101 | 0.123 | Somatostatin 1 agonist | 0.123 0.022 DBMET02111 | DBMET02111 | |
| 0.018 | 0.065 | 0.029 | Myristoyl transferase inhibitor | 0.029 0.015 DBMET02111 | DBMET02111 | |
| 0.039 | 0.087 | 0.059 | Acetylcholine M5 receptor antagonist | 0.059 0.044 DBMET02113 | DBMET02113 | |
| 0.046 | 0.094 | 0.077 | Corticotropin releasing factor 2 receptor antagonist | 0.065 0.036 DBMET02111 0.077 0.019 DBMET02113 | DBMET02113 | |
| 0.003 | 0.051 | 0.011 | DNA topoisomerase III inhibitor | 0.011 0.003 DBMET02113 | DBMET02113 | |
| 0.076 | 0.125 | 0.247 | GABA C receptor antagonist | 0.114 0.059 DBMET02111 0.247 0.007 DBMET02113 0.145 0.033 DBMET02112 | DBMET02113 | |
| 0.06 | 0.11 | 0.172 | GABA B receptor agonist | 0.093 0.022 DBMET02111 0.172 0.004 DBMET02113 0.12 0.008 DBMET02112 | DBMET02113 | |
| 0.072 | 0.122 | 0.188 | GABA C receptor rho-1 antagonist | 0.102 0.059 DBMET02111 0.188 0.01 DBMET02113 0.129 0.033 DBMET02112 | DBMET02113 | |
| 0.034 | 0.084 | 0.075 | Potassium channel (ATP-sensitive) activator | 0.075 0.008 DBMET02113 | DBMET02113 | |
| 0.035 | 0.086 | 0.078 | Potassium channel (Inward rectifier) activator | 0.078 0.008 DBMET02113 | DBMET02113 | |
| 0.026 | 0.078 | 0.046 | AMPA 4 receptor antagonist | 0.046 0.019 DBMET02113 | DBMET02113 | |
| 0.071 | 0.124 | 0.496 | Cystathionine beta-synthase inhibitor | 0.496 0.004 DBMET02113 0.29 0.01 DBMET02112 | DBMET02113 | |
| 0.02 | 0.072 | 0.034 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.034 0.008 DBMET02113 | DBMET02113 | |
| 0.031 | 0.084 | 0.108 | CF transmembrane conductance regulator antagonist | 0.108 0.003 DBMET02113 | DBMET02113 | |
| 0.042 | 0.096 | 0.216 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.041 DBMET02111 0.216 0.006 DBMET02113 0.193 0.007 DBMET02112 | DBMET02113 | |
| 0.029 | 0.087 | 0.131 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.131 0.002 DBMET02113 0.058 0.009 DBMET02112 | DBMET02113 | |
| 0.147 | 0.207 | 0.392 | RNA-directed DNA polymerase inhibitor | 0.169 0.154 DBMET02111 0.392 0.019 DBMET02113 0.281 0.036 DBMET02112 | DBMET02113 | |
| 0.018 | 0.077 | 0.028 | MAP3K8 inhibitor | 0.028 0.022 DBMET02113 | DBMET02113 | |
| 0.032 | 0.092 | 0.048 | Benzodiazepine antagonist | 0.048 0.031 DBMET02113 | DBMET02113 | |
| 0.069 | 0.13 | 0.221 | Electrolyte absorption antagonist | 0.221 0.006 DBMET02113 0.188 0.01 DBMET02112 | DBMET02113 | |
| 0.063 | 0.127 | 0.522 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.228 0.012 DBMET02111 0.329 0.005 DBMET02113 0.522 0.002 DBMET02112 | DBMET02112 | |
| 0.037 | 0.101 | 0.086 | Botulinum neurotoxin type A inhibitor | 0.072 0.023 DBMET02111 0.086 0.014 DBMET02113 0.065 0.031 DBMET02112 | DBMET02113 | |
| 0.013 | 0.078 | 0.043 | Kainate receptor 2 antagonist | 0.043 0.02 DBMET02113 | DBMET02113 | |
| 0.062 | 0.127 | 0.303 | Triose-phosphate isomerase inhibitor | 0.217 0.009 DBMET02113 0.303 0.005 DBMET02112 | DBMET02112 | |
| 0.053 | 0.12 | 0.086 | I kappa B kinase inhibitor | 0.086 0.053 DBMET02113 | DBMET02113 | |
| 0.098 | 0.165 | 0.188 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.084 DBMET02111 0.188 0.011 DBMET02113 0.187 0.012 DBMET02112 | DBMET02113 | |
| 0.033 | 0.101 | 0.057 | Heme oxygenase inhibitor | 0.057 0.008 DBMET02113 0.041 0.039 DBMET02112 | DBMET02113 | |
| 0.01 | 0.078 | 0.049 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.049 0.009 DBMET02113 0.032 0.015 DBMET02112 | DBMET02113 | |
| 0.006 | 0.075 | 0.025 | Cyclin T1 inhibitor | 0.025 0.007 DBMET02113 | DBMET02113 | |
| 0.036 | 0.105 | 0.225 | Sphingosine 1-phosphate receptor 4 agonist | 0.132 0.013 DBMET02111 0.15 0.008 DBMET02113 0.225 0.004 DBMET02112 | DBMET02112 | |
| 0.028 | 0.097 | 0.06 | CC chemokine 4 receptor antagonist | 0.046 0.033 DBMET02111 0.06 0.016 DBMET02113 | DBMET02113 | |
| 0.032 | 0.102 | 0.178 | Carbamoyl phosphate synthetase inhibitor | 0.142 0.012 DBMET02113 0.178 0.009 DBMET02112 | DBMET02112 | |
| 0.025 | 0.098 | 0.059 | Thymidine kinase inhibitor | 0.044 0.024 DBMET02111 0.059 0.014 DBMET02113 0.044 0.024 DBMET02112 | DBMET02113 | |
| 0.04 | 0.113 | 0.097 | Na+ K+ transporting ATPase inhibitor | 0.097 0.034 DBMET02113 | DBMET02113 | |
| 0.102 | 0.175 | 0.198 | Adenylate cyclase stimulant | 0.173 0.033 DBMET02111 0.198 0.015 DBMET02113 0.164 0.043 DBMET02112 | DBMET02113 | |
| 0.003 | 0.077 | 0.013 | Thyroid hormone beta agonist | 0.013 0.004 DBMET02113 0.011 0.005 DBMET02112 | DBMET02113 | |
| 0.062 | 0.136 | 0.369 | GABA C receptor agonist | 0.093 0.074 DBMET02111 0.369 0.006 DBMET02113 0.201 0.02 DBMET02112 | DBMET02113 | |
| 0.013 | 0.088 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 DBMET02112 | DBMET02112 | |
| 0.059 | 0.134 | 0.344 | Creatine kinase inhibitor | 0.344 0.004 DBMET02113 0.179 0.014 DBMET02112 | DBMET02113 | |
| 0.02 | 0.095 | 0.047 | Growth hormone release inhibitor | 0.047 0.024 DBMET02111 | DBMET02111 | |
| 0.029 | 0.104 | 0.081 | Purinergic P2X4 antagonist | 0.081 0.006 DBMET02113 | DBMET02113 | |
| 0.013 | 0.092 | 0.032 | Methionyl aminopeptidase 1 inhibitor | 0.032 0.022 DBMET02113 | DBMET02113 | |
| 0.018 | 0.097 | 0.059 | Somatostatin 5 agonist | 0.059 0.009 DBMET02111 | DBMET02111 | |
| 0.094 | 0.173 | 0.24 | Arachidonic acid antagonist | 0.239 0.008 DBMET02113 0.24 0.008 DBMET02112 | DBMET02112 | |
| 0.01 | 0.089 | 0.082 | Glucagon receptor antagonist | 0.039 0.014 DBMET02113 0.082 0.005 DBMET02112 | DBMET02112 | |
| 0.054 | 0.135 | 0.115 | Vanilloid 4 agonist | 0.08 0.04 DBMET02111 0.115 0.008 DBMET02113 0.09 0.026 DBMET02112 | DBMET02113 | |
| 0.078 | 0.159 | 0.272 | NADPH oxidase inhibitor | 0.272 0.016 DBMET02113 | DBMET02113 | |
| 0.048 | 0.129 | 0.109 | Glutamate (mGluR6) antagonist | 0.109 0.008 DBMET02113 0.106 0.009 DBMET02112 | DBMET02113 | |
| 0.002 | 0.083 | 0.013 | Progesterone receptor A antagonist | 0.013 0.004 DBMET02113 | DBMET02113 | |
| 0.008 | 0.091 | 0.014 | Integrin beta6 antagonist | 0.014 0.01 DBMET02113 | DBMET02113 | |
| 0.176 | 0.26 | 0.368 | Antibacterial | 0.339 0.109 DBMET02111 0.368 0.092 DBMET02113 0.256 0.172 DBMET02112 | DBMET02113 | |
| 0.129 | 0.214 | 0.315 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.315 0.019 DBMET02113 0.24 0.047 DBMET02112 | DBMET02113 | |
| 0.03 | 0.116 | 0.102 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.102 0.014 DBMET02113 0.085 0.018 DBMET02112 | DBMET02113 | |
| 0.009 | 0.096 | 0.02 | CC chemokine 9 receptor antagonist | 0.02 0.007 DBMET02113 0.016 0.015 DBMET02112 | DBMET02113 | |
| 0.013 | 0.101 | 0.046 | Thyroid hormone agonist | 0.046 0.005 DBMET02113 0.04 0.006 DBMET02112 | DBMET02113 | |
| 0.012 | 0.102 | 0.042 | Sodium/glucose cotransporter inhibitor | 0.042 0.006 DBMET02113 0.027 0.015 DBMET02112 | DBMET02113 | |
| 0.025 | 0.115 | 0.043 | Histamine H1 receptor agonist | 0.043 0.032 DBMET02113 | DBMET02113 | |
| 0.022 | 0.112 | 0.056 | Dopamine D4 antagonist | 0.056 0.044 DBMET02113 | DBMET02113 | |
| 0.013 | 0.103 | 0.041 | Kainate receptor antagonist | 0.041 0.028 DBMET02113 | DBMET02113 | |
| 0.085 | 0.176 | 0.229 | Sphingosine 1-phosphate receptor 4 antagonist | 0.12 0.072 DBMET02111 0.183 0.014 DBMET02113 0.229 0.005 DBMET02112 | DBMET02112 | |
| 0.063 | 0.156 | 0.104 | Acetylcholine muscarinic antagonist | 0.104 0.086 DBMET02113 | DBMET02113 | |
| 0.108 | 0.201 | 0.243 | 3C-like protease (Human coronavirus) inhibitor | 0.243 0.03 DBMET02113 0.158 0.088 DBMET02112 | DBMET02113 | |
| 0.019 | 0.114 | 0.036 | Membrane dipeptidase inhibitor | 0.036 0.034 DBMET02112 | DBMET02112 | |
| 0.033 | 0.129 | 0.109 | Epithelial sodium channel blocker | 0.109 0.005 DBMET02111 0.061 0.028 DBMET02113 | DBMET02111 | |
| 0.011 | 0.108 | 0.034 | Nicotinic acid receptor 2 antagonist | 0.034 0.009 DBMET02113 | DBMET02113 | |
| 0.059 | 0.156 | 0.115 | Bromodomain-containing protein 2 inhibitor | 0.115 0.026 DBMET02113 | DBMET02113 | |
| 0.036 | 0.134 | 0.085 | 5 Hydroxytryptamine 3 agonist | 0.085 0.023 DBMET02113 | DBMET02113 | |
| 0.12 | 0.218 | 0.194 | Cyclic AMP phosphodiesterase inhibitor | 0.194 0.098 DBMET02113 | DBMET02113 | |
| 0.009 | 0.108 | 0.03 | AMPA 3 receptor antagonist | 0.03 0.02 DBMET02113 | DBMET02113 | |
| 0.102 | 0.201 | 0.453 | Insulin sensitizer | 0.238 0.042 DBMET02111 0.203 0.071 DBMET02113 0.453 0.004 DBMET02112 | DBMET02112 | |
| 0.04 | 0.139 | 0.098 | Calcium antagonist | 0.077 0.067 DBMET02113 0.098 0.049 DBMET02112 | DBMET02112 | |
| 0.033 | 0.134 | 0.403 | Histidine decarboxylase inhibitor | 0.083 0.04 DBMET02111 0.403 0.004 DBMET02113 0.224 0.011 DBMET02112 | DBMET02113 | |
| 0.009 | 0.11 | 0.056 | Sodium/glucose cotransporter 2 inhibitor | 0.056 0.005 DBMET02113 0.028 0.015 DBMET02112 | DBMET02113 | |
| 0.058 | 0.16 | 0.149 | Anabolic | 0.149 0.018 DBMET02113 0.124 0.035 DBMET02112 | DBMET02113 | |
| 0.012 | 0.117 | 0.122 | Fumarate hydratase inhibitor | 0.064 0.009 DBMET02113 0.122 0.004 DBMET02112 | DBMET02112 | |
| 0.026 | 0.132 | 0.074 | Alpha-mannosidase inhibitor | 0.067 0.02 DBMET02113 0.074 0.014 DBMET02112 | DBMET02112 | |
| 0.019 | 0.125 | 0.061 | Mannosidase inhibitor | 0.055 0.021 DBMET02113 0.061 0.016 DBMET02112 | DBMET02112 | |
| 0.06 | 0.167 | 0.173 | D-Ala-D-Ala ligase inhibitor | 0.173 0.004 DBMET02113 0.107 0.022 DBMET02112 | DBMET02113 | |
| 0.062 | 0.169 | 0.164 | Beta glucuronidase inhibitor | 0.164 0.02 DBMET02113 | DBMET02113 | |
| 0.014 | 0.121 | 0.046 | Urokinase inhibitor | 0.046 0.035 DBMET02111 | DBMET02111 | |
| 0.032 | 0.141 | 0.064 | Benzodiazepine agonist | 0.064 0.06 DBMET02113 | DBMET02113 | |
| 0.003 | 0.112 | 0.19 | Peroxisome proliferator-activated receptor alpha antagonist | 0.19 0.003 DBMET02112 | DBMET02112 | |
| 0.05 | 0.159 | 0.16 | Sphingomyelinase inhibitor | 0.123 0.039 DBMET02111 0.16 0.021 DBMET02113 0.103 0.056 DBMET02112 | DBMET02113 | |
| 0.058 | 0.169 | 0.145 | ABCA1 expression enhancer | 0.145 0.019 DBMET02112 | DBMET02112 | |
| 0.015 | 0.126 | 0.034 | Melanocortin 1 antagonist | 0.034 0.031 DBMET02111 | DBMET02111 | |
| 0.027 | 0.138 | 0.211 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.211 0.004 DBMET02113 0.079 0.017 DBMET02112 | DBMET02113 | |
| 0.005 | 0.117 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.024 0.023 DBMET02113 | DBMET02113 | |
| 0.037 | 0.149 | 0.095 | Aryl hydrocarbon receptor antagonist | 0.095 0.016 DBMET02113 | DBMET02113 | |
| 0.066 | 0.179 | 0.126 | Glutamate (mGluR7) agonist | 0.095 0.07 DBMET02111 0.126 0.024 DBMET02113 0.094 0.072 DBMET02112 | DBMET02113 | |
| 0.026 | 0.139 | 0.073 | TRPA1 antagonist | 0.073 0.03 DBMET02113 | DBMET02113 | |
| 0.011 | 0.124 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.014 DBMET02113 0.018 0.013 DBMET02112 | DBMET02112 | |
| 0.007 | 0.121 | 0.015 | Purinergic P2Y1 agonist | 0.015 0.011 DBMET02113 | DBMET02113 | |
| 0.132 | 0.246 | 0.276 | ErbB-1 antagonist | 0.276 0.04 DBMET02113 | DBMET02113 | |
| 0.05 | 0.165 | 0.111 | MDM2 inhibitor | 0.098 0.008 DBMET02113 0.111 0.005 DBMET02112 | DBMET02112 | |
| 0.006 | 0.123 | 0.021 | Telomerase stimulant | 0.021 0.007 DBMET02113 | DBMET02113 | |
| 0.026 | 0.144 | 0.057 | NMDA 2B receptor antagonist | 0.057 0.034 DBMET02113 | DBMET02113 | |
| 0.038 | 0.156 | 0.112 | Androgen antagonist | 0.112 0.038 DBMET02113 0.088 0.056 DBMET02112 | DBMET02113 | |
| 0.009 | 0.129 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 DBMET02113 | DBMET02113 | |
| 0.021 | 0.141 | 0.098 | Acyl-CoA dehydrogenase inhibitor | 0.082 0.021 DBMET02111 0.097 0.017 DBMET02113 0.098 0.017 DBMET02112 | DBMET02112 | |
| 0.009 | 0.129 | 0.029 | Isoleucine-tRNA ligase inhibitor | 0.029 0.006 DBMET02113 0.025 0.01 DBMET02112 | DBMET02113 | |
| 0.064 | 0.187 | 0.116 | Sodium channel (voltage-gated) blocker | 0.116 0.089 DBMET02113 | DBMET02113 | |
| 0.044 | 0.167 | 0.246 | Peroxisome proliferator-activated receptor gamma antagonist | 0.076 0.04 DBMET02113 0.246 0.004 DBMET02112 | DBMET02112 | |
| 0.013 | 0.136 | 0.108 | ATP citrate lysase inhibitor | 0.103 0.003 DBMET02113 0.108 0.003 DBMET02112 | DBMET02112 | |
| 0.025 | 0.149 | 0.104 | Glucose-6-phosphate isomerase inhibitor | 0.087 0.007 DBMET02113 0.104 0.004 DBMET02112 | DBMET02112 | |
| 0.021 | 0.145 | 0.059 | Lysophosphatidic acid 3 receptor antagonist | 0.051 0.034 DBMET02113 0.059 0.024 DBMET02112 | DBMET02112 | |
| 0.086 | 0.21 | 0.376 | Anesthetic general | 0.376 0.02 DBMET02113 0.283 0.038 DBMET02112 | DBMET02113 | |
| 0.03 | 0.155 | 0.076 | Nicotinic alpha3beta2 receptor antagonist | 0.076 0.015 DBMET02113 | DBMET02113 | |
| 0.095 | 0.221 | 0.189 | Sphingosine 1-phosphate receptor 5 antagonist | 0.189 0.017 DBMET02113 0.184 0.021 DBMET02112 | DBMET02113 | |
| 0.009 | 0.135 | 0.07 | Liver X receptor beta antagonist | 0.07 0.005 DBMET02113 0.029 0.02 DBMET02112 | DBMET02113 | |
| 0.018 | 0.145 | 0.101 | NMDA 2C receptor antagonist | 0.101 0.015 DBMET02113 0.056 0.051 DBMET02112 | DBMET02113 | |
| 0.032 | 0.159 | 0.147 | Purinergic P2X1 antagonist | 0.147 0.007 DBMET02113 0.075 0.028 DBMET02112 | DBMET02113 | |
| 0.078 | 0.205 | 0.201 | Cell wall synthesis inhibitor | 0.201 0.029 DBMET02111 0.183 0.038 DBMET02113 0.185 0.037 DBMET02112 | DBMET02111 | |
| 0.128 | 0.255 | 0.284 | DNA synthesis inhibitor | 0.19 0.138 DBMET02111 0.284 0.049 DBMET02113 0.241 0.073 DBMET02112 | DBMET02113 | |
| 0.017 | 0.144 | 0.06 | Adenosine deaminase inhibitor | 0.06 0.021 DBMET02113 0.045 0.035 DBMET02112 | DBMET02113 | |
| 0.072 | 0.2 | 0.211 | Interleukin 8 antagonist | 0.124 0.056 DBMET02111 0.211 0.01 DBMET02113 0.165 0.025 DBMET02112 | DBMET02113 | |
| 0.056 | 0.185 | 0.331 | Amylase inhibitor | 0.331 0.015 DBMET02113 0.313 0.017 DBMET02112 | DBMET02113 | |
| 0.119 | 0.248 | 0.428 | Superoxide dismutase inhibitor | 0.315 0.045 DBMET02111 0.428 0.022 DBMET02113 0.275 0.061 DBMET02112 | DBMET02113 | |
| 0.016 | 0.147 | 0.039 | Hedgehog signaling activator | 0.039 0.005 DBMET02113 | DBMET02113 | |
| 0.008 | 0.139 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 DBMET02113 | DBMET02113 | |
| 0.009 | 0.139 | 0.024 | Lysophosphatidic acid 1 receptor antagonist | 0.024 0.01 DBMET02112 | DBMET02112 | |
| 0.028 | 0.159 | 0.082 | Sphingosine kinase 2 inhibitor | 0.082 0.014 DBMET02113 | DBMET02113 | |
| 0.009 | 0.141 | 0.05 | Prostaglandin F2 alpha agonist | 0.033 0.008 DBMET02113 0.05 0.004 DBMET02112 | DBMET02112 | |
| 0.065 | 0.199 | 0.134 | Photosensitizer | 0.134 0.043 DBMET02113 0.099 0.09 DBMET02112 | DBMET02113 | |
| 0.005 | 0.14 | 0.024 | Thromboxane A2 agonist | 0.024 0.004 DBMET02113 0.022 0.005 DBMET02112 | DBMET02113 | |
| 0.112 | 0.247 | 0.264 | DNA damaging | 0.264 0.073 DBMET02113 | DBMET02113 | |
| 0.055 | 0.191 | 0.12 | Granulocyte macrophage colony stimulating factor agonist | 0.12 0.015 DBMET02113 0.081 0.074 DBMET02112 | DBMET02113 | |
| 0.006 | 0.144 | 0.052 | Uridine phosphorylase inhibitor | 0.047 0.009 DBMET02113 0.052 0.008 DBMET02112 | DBMET02112 | |
| 0.02 | 0.158 | 0.099 | Argininosuccinate synthase inhibitor | 0.099 0.019 DBMET02113 0.093 0.021 DBMET02112 | DBMET02113 | |
| 0.052 | 0.19 | 0.117 | Bile acid receptor antagonist | 0.117 0.023 DBMET02113 0.105 0.04 DBMET02112 | DBMET02113 | |
| 0.013 | 0.151 | 0.041 | Inosine monophosphate dehydrogenase inhibitor | 0.041 0.021 DBMET02113 | DBMET02113 | |
| 0.042 | 0.181 | 0.157 | Glycine receptor agonist | 0.157 0.006 DBMET02113 0.108 0.017 DBMET02112 | DBMET02113 | |
| 0.023 | 0.163 | 0.06 | Kainate receptor agonist | 0.06 0.007 DBMET02113 0.054 0.01 DBMET02112 | DBMET02113 | |
| 0.038 | 0.18 | 0.092 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.092 0.02 DBMET02113 | DBMET02113 | |
| 0.052 | 0.194 | 0.096 | MAP kinase kinase 7 inhibitor | 0.096 0.017 DBMET02113 | DBMET02113 | |
| 0.012 | 0.155 | 0.036 | Integrin alpha2beta1 antagonist | 0.036 0.008 DBMET02113 0.026 0.019 DBMET02112 | DBMET02113 | |
| 0.087 | 0.231 | 0.269 | Melanin inhibitor | 0.269 0.026 DBMET02113 0.176 0.055 DBMET02112 | DBMET02113 | |
| 0.004 | 0.148 | 0.014 | NMDA receptor phencyclidine site antagonist | 0.014 0.012 DBMET02113 | DBMET02113 | |
| 0.094 | 0.239 | 0.149 | Death-associated protein kinase 1 inhibitor | 0.149 0.04 DBMET02113 | DBMET02113 | |
| 0.018 | 0.164 | 0.06 | Acetylcholine M3 receptor antagonist | 0.06 0.041 DBMET02113 | DBMET02113 | |
| 0.002 | 0.148 | 0.013 | Thromboxane agonist | 0.013 0.005 DBMET02113 0.013 0.005 DBMET02112 | DBMET02112 | |
| 0.031 | 0.177 | 0.063 | Glucosylceramidase inhibitor | 0.063 0.028 DBMET02113 | DBMET02113 | |
| 0.037 | 0.184 | 0.194 | Glutamate dehydrogenase inhibitor | 0.072 0.054 DBMET02111 0.149 0.016 DBMET02113 0.194 0.01 DBMET02112 | DBMET02112 | |
| 0.02 | 0.169 | 0.043 | Potassium channel Kv1.1 blocker | 0.043 0.019 DBMET02113 | DBMET02113 | |
| 0.013 | 0.164 | 0.087 | NMDA 2A receptor antagonist | 0.087 0.017 DBMET02113 | DBMET02113 | |
| 0.024 | 0.177 | 0.102 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.037 DBMET02111 0.068 0.028 DBMET02113 0.102 0.008 DBMET02112 | DBMET02112 | |
| 0.036 | 0.19 | 0.075 | Potassium channel (Tandem pore domain) blocker | 0.075 0.047 DBMET02113 | DBMET02113 | |
| 0.052 | 0.207 | 0.095 | mTOR complex 2 inhibitor | 0.095 0.039 DBMET02113 | DBMET02113 | |
| 0.019 | 0.174 | 0.252 | Alcohol oxidase inhibitor | 0.252 0.005 DBMET02113 0.198 0.007 DBMET02112 | DBMET02113 | |
| 0.029 | 0.186 | 0.127 | Sphingosine 1-phosphate receptor 1 antagonist | 0.081 0.014 DBMET02113 0.127 0.005 DBMET02112 | DBMET02112 | |
| 0.022 | 0.18 | 0.06 | GABA B receptor antagonist | 0.06 0.012 DBMET02113 0.045 0.025 DBMET02112 | DBMET02113 | |
| 0.006 | 0.163 | 0.063 | CXC chemokine 2 receptor antagonist | 0.063 0.005 DBMET02113 | DBMET02113 | |
| 0.044 | 0.202 | 0.087 | Calcium channel P-type blocker | 0.087 0.01 DBMET02113 0.085 0.011 DBMET02112 | DBMET02113 | |
| 0.014 | 0.172 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 DBMET02113 | DBMET02113 | |
| 0.003 | 0.162 | 0.021 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.021 0.004 DBMET02113 | DBMET02113 | |
| 0.02 | 0.179 | 0.111 | Biliverdin reductase inhibitor | 0.11 0.016 DBMET02113 0.111 0.016 DBMET02112 | DBMET02112 | |
| 0.016 | 0.176 | 0.133 | NMDA 2 receptor antagonist | 0.133 0.02 DBMET02113 | DBMET02113 | |
| 0.124 | 0.285 | 0.292 | Peptidyltransferase inhibitor | 0.292 0.028 DBMET02111 0.206 0.092 DBMET02113 0.23 0.067 DBMET02112 | DBMET02111 | |
| 0.023 | 0.184 | 0.062 | Cannabinoid CB1 receptor antagonist | 0.062 0.042 DBMET02113 | DBMET02113 | |
| 0.01 | 0.172 | 0.138 | Sphingosine 1-phosphate receptor 1 agonist | 0.06 0.013 DBMET02111 0.04 0.032 DBMET02113 0.138 0.004 DBMET02112 | DBMET02112 | |
| 0.087 | 0.25 | 0.229 | Interferon gamma antagonist | 0.229 0.033 DBMET02113 0.187 0.046 DBMET02112 | DBMET02113 | |
| 0.029 | 0.191 | 0.093 | Dihydroorotate oxidase inhibitor | 0.093 0.006 DBMET02113 | DBMET02113 | |
| 0.123 | 0.286 | 0.174 | MAP kinase kinase 5 inhibitor | 0.174 0.075 DBMET02111 0.154 0.138 DBMET02113 0.157 0.127 DBMET02112 | DBMET02111 | |
| 0.045 | 0.208 | 0.323 | Cholesterol synthesis inhibitor | 0.208 0.025 DBMET02113 0.323 0.009 DBMET02112 | DBMET02112 | |
| 0.006 | 0.169 | 0.028 | Thyroid hormone alpha agonist | 0.028 0.004 DBMET02113 0.016 0.011 DBMET02112 | DBMET02113 | |
| 0.094 | 0.258 | 0.295 | Neurotrophic factor enhancer | 0.295 0.019 DBMET02113 0.22 0.059 DBMET02112 | DBMET02113 | |
| 0.016 | 0.182 | 0.066 | Nerve growth factor antagonist | 0.066 0.007 DBMET02113 | DBMET02113 | |
| 0.059 | 0.224 | 0.206 | DOPA decarboxylase inhibitor | 0.206 0.006 DBMET02113 0.132 0.033 DBMET02112 | DBMET02113 | |
| 0.034 | 0.2 | 0.062 | Interferon inducer | 0.062 0.05 DBMET02113 | DBMET02113 | |
| 0.056 | 0.222 | 0.127 | Estrogen-related receptor beta agonist | 0.127 0.008 DBMET02113 0.089 0.043 DBMET02112 | DBMET02113 | |
| 0.029 | 0.197 | 0.114 | Aminopeptidase I inhibitor | 0.099 0.028 DBMET02111 0.106 0.025 DBMET02113 0.114 0.022 DBMET02112 | DBMET02112 | |
| 0.01 | 0.177 | 0.059 | Liver X receptor beta agonist | 0.059 0.008 DBMET02113 0.055 0.009 DBMET02112 | DBMET02113 | |
| 0.088 | 0.256 | 0.173 | Pregnane X receptor agonist | 0.173 0.024 DBMET02113 | DBMET02113 | |
| 0.02 | 0.19 | 0.058 | Cholesterol esterase inhibitor | 0.055 0.023 DBMET02113 0.058 0.02 DBMET02112 | DBMET02112 | |
| 0.01 | 0.18 | 0.244 | Peroxisome proliferator-activated receptor alpha agonist | 0.244 0.004 DBMET02112 | DBMET02112 | |
| 0.003 | 0.173 | 0.017 | Carbonic anhydrase X inhibitor | 0.017 0.012 DBMET02112 | DBMET02112 | |
| 0.003 | 0.173 | 0.017 | Carbonic anhydrase VIII inhibitor | 0.017 0.012 DBMET02112 | DBMET02112 | |
| 0.081 | 0.251 | 0.193 | I kappa B kinase epsilon inhibitor | 0.193 0.077 DBMET02113 | DBMET02113 | |
| 0.099 | 0.268 | 0.324 | Cardiotonic | 0.187 0.132 DBMET02111 0.324 0.047 DBMET02112 | DBMET02112 | |
| 0.021 | 0.192 | 0.119 | Leukotriene antagonist | 0.062 0.048 DBMET02113 0.119 0.015 DBMET02112 | DBMET02112 | |
| 0.01 | 0.181 | 0.032 | Vanilloid 2 agonist | 0.032 0.008 DBMET02113 | DBMET02113 | |
| 0.029 | 0.2 | 0.082 | Cathepsin G inhibitor | 0.082 0.042 DBMET02113 0.077 0.046 DBMET02112 | DBMET02113 | |
| 0.018 | 0.189 | 0.062 | Acetylcholine M5 receptor agonist | 0.062 0.053 DBMET02113 | DBMET02113 | |
| 0.05 | 0.222 | 0.183 | Adenylate cyclase inhibitor | 0.183 0.029 DBMET02111 0.162 0.038 DBMET02113 0.158 0.04 DBMET02112 | DBMET02111 | |
| 0.027 | 0.199 | 0.06 | 5 Hydroxytryptamine 7 agonist | 0.06 0.031 DBMET02113 | DBMET02113 | |
| 0.01 | 0.183 | 0.062 | Guanylate cyclase inhibitor | 0.062 0.01 DBMET02113 0.044 0.028 DBMET02112 | DBMET02113 | |
| 0.008 | 0.182 | 0.191 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.191 0.004 DBMET02113 | DBMET02113 | |
| 0.019 | 0.194 | 0.065 | Glutamate (mGluR8) agonist | 0.065 0.005 DBMET02113 0.049 0.012 DBMET02112 | DBMET02113 | |
| 0.07 | 0.247 | 0.184 | Transcription factor STAT6 inhibitor | 0.184 0.009 DBMET02113 | DBMET02113 | |
| 0.019 | 0.196 | 0.091 | Adenylate cyclase 1 inhibitor | 0.091 0.005 DBMET02111 0.089 0.005 DBMET02113 0.073 0.011 DBMET02112 | DBMET02111 | |
| 0.035 | 0.213 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.074 0.073 DBMET02111 0.085 0.054 DBMET02113 | DBMET02113 | |
| 0.084 | 0.262 | 0.157 | Antipruritic | 0.157 0.087 DBMET02113 | DBMET02113 | |
| 0.026 | 0.205 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.035 DBMET02111 0.046 0.039 DBMET02113 | DBMET02111 | |
| 0.012 | 0.191 | 0.056 | Oxytocin agonist | 0.056 0.02 DBMET02113 | DBMET02113 | |
| 0.032 | 0.212 | 0.181 | GABA aminotransferase inhibitor | 0.074 0.055 DBMET02111 0.181 0.005 DBMET02113 0.123 0.015 DBMET02112 | DBMET02113 | |
| 0.025 | 0.205 | 0.157 | Glutamate decarboxylase inhibitor | 0.156 0.012 DBMET02113 0.157 0.012 DBMET02112 | DBMET02112 | |
| 0.018 | 0.198 | 0.188 | Phosphofructokinase-1 inhibitor | 0.161 0.016 DBMET02113 0.188 0.012 DBMET02112 | DBMET02112 | |
| 0.007 | 0.187 | 0.025 | Lysine carboxypeptidase inhibitor | 0.025 0.02 DBMET02113 0.025 0.022 DBMET02112 | DBMET02112 | |
| 0.025 | 0.205 | 0.059 | Topoisomerase II beta inhibitor | 0.059 0.023 DBMET02113 0.058 0.024 DBMET02112 | DBMET02113 | |
| 0.008 | 0.19 | 0.097 | Dopamine D5 antagonist | 0.097 0.009 DBMET02113 | DBMET02113 | |
| 0.01 | 0.192 | 0.022 | ICAM 1 antagonist | 0.022 0.018 DBMET02113 0.021 0.02 DBMET02112 | DBMET02113 | |
| 0.057 | 0.239 | 0.107 | Nav1.5 sodium channel blocker | 0.107 0.072 DBMET02113 | DBMET02113 | |
| 0.015 | 0.197 | 0.047 | Integrin alpha2 antagonist | 0.047 0.013 DBMET02113 0.035 0.03 DBMET02112 | DBMET02113 | |
| 0.006 | 0.19 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.023 DBMET02113 | DBMET02113 | |
| 0.007 | 0.192 | 0.091 | Urate transporter 1 inhibitor | 0.091 0.006 DBMET02113 0.043 0.023 DBMET02112 | DBMET02113 | |
| 0.011 | 0.196 | 0.062 | Ornithine carbamoyltransferase inhibitor | 0.059 0.032 DBMET02113 0.062 0.03 DBMET02112 | DBMET02112 | |
| 0.005 | 0.19 | 0.028 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.028 0.01 DBMET02113 | DBMET02113 | |
| 0.036 | 0.223 | 0.062 | Immunoglobulin Fc receptor antagonist | 0.056 0.036 DBMET02111 0.062 0.02 DBMET02113 0.056 0.035 DBMET02112 | DBMET02113 | |
| 0.009 | 0.196 | 0.054 | Geranyltranstransferase inhibitor | 0.054 0.019 DBMET02113 | DBMET02113 | |
| 0.016 | 0.204 | 0.157 | NMDA receptor glycine site agonist | 0.065 0.041 DBMET02111 0.125 0.008 DBMET02113 0.157 0.004 DBMET02112 | DBMET02112 | |
| 0.017 | 0.206 | 0.062 | EphB4 antagonist | 0.062 0.036 DBMET02113 | DBMET02113 | |
| 0.015 | 0.209 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.025 DBMET02113 | DBMET02113 | |
| 0.118 | 0.312 | 0.318 | Vasodilator, coronary | 0.256 0.128 DBMET02111 0.275 0.11 DBMET02113 0.318 0.074 DBMET02112 | DBMET02112 | |
| 0.004 | 0.199 | 0.047 | NMDA receptor glycine site antagonist | 0.047 0.006 DBMET02113 0.029 0.014 DBMET02112 | DBMET02113 | |
| 0.002 | 0.197 | 0.052 | Prostaglandin EP4 agonist | 0.052 0.005 DBMET02112 | DBMET02112 | |
| 0.012 | 0.208 | 0.054 | Potassium channel Kv1.3 blocker | 0.054 0.026 DBMET02113 | DBMET02113 | |
| 0.01 | 0.207 | 0.13 | Phosphorylase inhibitor | 0.056 0.027 DBMET02111 0.066 0.022 DBMET02113 0.13 0.009 DBMET02112 | DBMET02112 | |
| 0.01 | 0.21 | 0.04 | Angiotensin AT1 receptor antagonist | 0.04 0.034 DBMET02113 | DBMET02113 | |
| 0.02 | 0.22 | 0.059 | Leukotriene B4 antagonist | 0.059 0.029 DBMET02112 | DBMET02112 | |
| 0.004 | 0.206 | 0.037 | Prostaglandin EP2 agonist | 0.022 0.016 DBMET02113 0.037 0.009 DBMET02112 | DBMET02112 | |
| 0.019 | 0.222 | 0.142 | Aconitate hydratase inhibitor | 0.098 0.009 DBMET02113 0.142 0.004 DBMET02112 | DBMET02112 | |
| 0.049 | 0.252 | 0.119 | Sodium channel blocker | 0.119 0.085 DBMET02111 | DBMET02111 | |
| 0.03 | 0.235 | 0.17 | Macrophage migration inhibitory factor inhibitor | 0.17 0.011 DBMET02113 0.07 0.066 DBMET02112 | DBMET02113 | |
| 0.004 | 0.21 | 0.018 | Complement factor D inhibitor | 0.018 0.013 DBMET02113 | DBMET02113 | |
| 0.002 | 0.208 | 0.011 | Beta 3 adrenoreceptor agonist | 0.011 0.008 DBMET02112 | DBMET02112 | |
| 0.031 | 0.237 | 0.074 | Interferon agonist | 0.074 0.063 DBMET02113 | DBMET02113 | |
| 0.021 | 0.228 | 0.07 | Cyclin D1 inhibitor | 0.07 0.029 DBMET02113 | DBMET02113 | |
| 0.013 | 0.221 | 0.155 | Sphingosine 1-phosphate receptor agonist | 0.06 0.016 DBMET02111 0.047 0.028 DBMET02113 0.155 0.004 DBMET02112 | DBMET02112 | |
| 0.02 | 0.228 | 0.091 | Androgen agonist | 0.091 0.019 DBMET02113 | DBMET02113 | |
| 0.025 | 0.233 | 0.177 | NMDA receptor agonist | 0.059 0.048 DBMET02111 0.127 0.012 DBMET02113 0.177 0.005 DBMET02112 | DBMET02112 | |
| 0.006 | 0.216 | 0.044 | Free fatty acid receptor 1 antagonist | 0.044 0.013 DBMET02113 0.042 0.014 DBMET02112 | DBMET02113 | |
| 0.065 | 0.276 | 0.306 | Mannose-6-phosphate isomerase inhibitor | 0.306 0.005 DBMET02113 0.248 0.012 DBMET02112 | DBMET02113 | |
| 0.025 | 0.238 | 0.061 | Potassium channel (ATP-sensitive) blocker | 0.061 0.058 DBMET02113 | DBMET02113 | |
| 0.019 | 0.233 | 0.253 | Catalase inhibitor | 0.158 0.024 DBMET02113 0.253 0.008 DBMET02112 | DBMET02112 | |
| 0.003 | 0.219 | 0.04 | Prostaglandin E2 agonist | 0.021 0.019 DBMET02113 0.04 0.007 DBMET02112 | DBMET02112 | |
| 0.023 | 0.239 | 0.111 | CYP2A6 inhibitor | 0.111 0.03 DBMET02113 | DBMET02113 | |
| 0.007 | 0.224 | 0.04 | Glutamate (mGluR group II) antagonist | 0.04 0.024 DBMET02113 0.034 0.033 DBMET02112 | DBMET02113 | |
| 0.015 | 0.231 | 0.04 | Sphingosine kinase 1 inhibitor | 0.04 0.032 DBMET02113 | DBMET02113 | |
| 0.014 | 0.232 | 0.046 | Estrogen-related receptor beta antagonist | 0.046 0.007 DBMET02113 | DBMET02113 | |
| 0.024 | 0.243 | 0.146 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.146 0.02 DBMET02113 0.089 0.044 DBMET02112 | DBMET02113 | |
| 0.021 | 0.242 | 0.042 | Leukotriene C4 antagonist | 0.042 0.02 DBMET02113 0.041 0.022 DBMET02112 | DBMET02113 | |
| 0.04 | 0.26 | 0.124 | Alkylator | 0.101 0.087 DBMET02111 0.124 0.064 DBMET02113 | DBMET02113 | |
| 0.05 | 0.272 | 0.183 | Cathepsin H inhibitor | 0.183 0.028 DBMET02111 0.16 0.04 DBMET02113 0.162 0.039 DBMET02112 | DBMET02111 | |
| 0.012 | 0.235 | 0.026 | Complement factor 1s inhibitor | 0.026 0.015 DBMET02113 | DBMET02113 | |
| 0.006 | 0.23 | 0.019 | Estrogen-related receptor gamma agonist | 0.019 0.011 DBMET02113 | DBMET02113 | |
| 0.005 | 0.233 | 0.066 | Retinoid X receptor agonist | 0.066 0.011 DBMET02112 | DBMET02112 | |
| 0.013 | 0.241 | 0.045 | Glutamate (mGluR3) agonist | 0.045 0.007 DBMET02113 0.034 0.019 DBMET02112 | DBMET02113 | |
| 0.008 | 0.236 | 0.045 | Dihydropteroate synthase inhibitor | 0.045 0.021 DBMET02113 | DBMET02113 | |
| 0.031 | 0.26 | 0.161 | Aminopeptidase B inhibitor | 0.148 0.039 DBMET02111 0.161 0.033 DBMET02113 0.156 0.035 DBMET02112 | DBMET02113 | |
| 0.031 | 0.261 | 0.064 | Leukotriene C antagonist | 0.064 0.022 DBMET02113 0.062 0.024 DBMET02112 | DBMET02113 | |
| 0.006 | 0.236 | 0.147 | Peroxisome proliferator-activated receptor delta agonist | 0.147 0.004 DBMET02112 | DBMET02112 | |
| 0.019 | 0.249 | 0.05 | Vanilloid 3 antagonist | 0.05 0.008 DBMET02113 | DBMET02113 | |
| 0.005 | 0.237 | 0.061 | Prostaglandin agonist | 0.031 0.021 DBMET02113 0.061 0.008 DBMET02112 | DBMET02112 | |
| 0.023 | 0.257 | 0.067 | Cyclin B3 inhibitor | 0.067 0.048 DBMET02113 | DBMET02113 | |
| 0.1 | 0.334 | 0.649 | Cholesterol antagonist | 0.288 0.099 DBMET02111 0.508 0.031 DBMET02113 0.649 0.013 DBMET02112 | DBMET02112 | |
| 0.003 | 0.237 | 0.03 | Prostaglandin H2 antagonist | 0.03 0.013 DBMET02113 | DBMET02113 | |
| 0.02 | 0.256 | 0.065 | Sphingosine kinase inhibitor | 0.065 0.031 DBMET02113 | DBMET02113 | |
| 0.032 | 0.269 | 0.138 | Sphingosine 1-phosphate receptor antagonist | 0.103 0.02 DBMET02113 0.138 0.008 DBMET02112 | DBMET02112 | |
| 0.021 | 0.258 | 0.046 | Glucagon-like peptide 1 receptor antagonist | 0.046 0.017 DBMET02112 | DBMET02112 | |
| 0.021 | 0.259 | 0.064 | Squalene epoxidase inhibitor | 0.064 0.017 DBMET02113 | DBMET02113 | |
| 0.019 | 0.258 | 0.064 | Cannabinoid receptor antagonist | 0.064 0.057 DBMET02113 | DBMET02113 | |
| 0.025 | 0.264 | 0.13 | Heat shock protein 90 beta antagonist | 0.13 0.005 DBMET02113 | DBMET02113 | |
| 0.019 | 0.259 | 0.25 | Porphobilinogen synthase inhibitor | 0.25 0.008 DBMET02113 0.121 0.028 DBMET02112 | DBMET02113 | |
| 0.02 | 0.262 | 0.056 | Glutamate (mGluR4) antagonist | 0.056 0.016 DBMET02113 | DBMET02113 | |
| 0.046 | 0.288 | 0.152 | Microtubule formation inhibitor | 0.152 0.037 DBMET02113 0.14 0.043 DBMET02112 | DBMET02113 | |
| 0.047 | 0.289 | 0.211 | Carbonic anhydrase XV inhibitor | 0.091 0.081 DBMET02111 0.211 0.017 DBMET02113 | DBMET02113 | |
| 0.039 | 0.282 | 0.145 | MAP kinase kinase 1 inhibitor | 0.094 0.064 DBMET02111 0.145 0.018 DBMET02113 | DBMET02113 | |
| 0.001 | 0.247 | 0.014 | Glutamate (mGluR6) agonist | 0.014 0.007 DBMET02113 | DBMET02113 | |
| 0.037 | 0.284 | 0.144 | Estrogen receptor alpha antagonist | 0.144 0.012 DBMET02113 | DBMET02113 | |
| 0.007 | 0.254 | 0.057 | Fructose-1,6-bisphosphatase inhibitor | 0.057 0.019 DBMET02113 | DBMET02113 | |
| 0.087 | 0.335 | 0.284 | Transcription factor NF kappa B inhibitor | 0.284 0.104 DBMET02113 | DBMET02113 | |
| 0.061 | 0.309 | 0.309 | Interleukin agonist | 0.309 0.044 DBMET02111 0.273 0.063 DBMET02113 0.277 0.061 DBMET02112 | DBMET02111 | |
| 0.007 | 0.257 | 0.027 | LFA antagonist | 0.027 0.021 DBMET02113 | DBMET02113 | |
| 0.013 | 0.264 | 0.051 | Dihydroorotase inhibitor | 0.051 0.023 DBMET02113 | DBMET02113 | |
| 0.035 | 0.287 | 0.131 | Interleukin 1 beta converting enzyme inhibitor | 0.086 0.079 DBMET02111 0.131 0.027 DBMET02113 0.115 0.04 DBMET02112 | DBMET02113 | |
| 0.005 | 0.258 | 0.033 | CC chemokine 1 receptor antagonist | 0.033 0.011 DBMET02113 | DBMET02113 | |
| 0.009 | 0.263 | 0.055 | GABA uptake inhibitor | 0.055 0.013 DBMET02113 | DBMET02113 | |
| 0.003 | 0.257 | 0.029 | Nicotinic acid receptor 1 antagonist | 0.029 0.004 DBMET02113 | DBMET02113 | |
| 0.005 | 0.259 | 0.088 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.088 0.005 DBMET02113 | DBMET02113 | |
| 0.005 | 0.259 | 0.029 | Glutamate (mGluR1a) agonist | 0.029 0.009 DBMET02113 | DBMET02113 | |
| 0.019 | 0.274 | 0.103 | MAO A inhibitor | 0.103 0.062 DBMET02113 | DBMET02113 | |
| 0.01 | 0.267 | 0.07 | Cathepsin L inhibitor | 0.07 0.03 DBMET02111 | DBMET02111 | |
| 0.017 | 0.274 | 0.033 | Adenosine uptake inhibitor | 0.033 0.032 DBMET02113 | DBMET02113 | |
| 0.011 | 0.268 | 0.031 | Carboxypeptidase B inhibitor | 0.031 0.027 DBMET02112 | DBMET02112 | |
| 0.011 | 0.269 | 0.037 | Delayed rectifier potassium channel blocker | 0.037 0.027 DBMET02113 | DBMET02113 | |
| 0.029 | 0.287 | 0.072 | Adenosine A3 receptor antagonist | 0.072 0.055 DBMET02113 | DBMET02113 | |
| 0.003 | 0.261 | 0.037 | Arginase inhibitor | 0.037 0.025 DBMET02113 0.036 0.026 DBMET02112 | DBMET02113 | |
| 0.002 | 0.262 | 0.028 | G-protein-coupled receptor 120 agonist | 0.016 0.013 DBMET02113 0.028 0.005 DBMET02112 | DBMET02112 | |
| 0.008 | 0.269 | 0.046 | Liver X receptor alpha antagonist | 0.046 0.007 DBMET02113 | DBMET02113 | |
| 0.004 | 0.266 | 0.068 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.068 0.005 DBMET02113 | DBMET02113 | |
| 0.04 | 0.306 | 0.208 | Carbonic anhydrase III inhibitor | 0.208 0.015 DBMET02113 0.102 0.06 DBMET02112 | DBMET02113 | |
| 0.112 | 0.378 | 0.503 | Histamine release inhibitor | 0.299 0.124 DBMET02111 0.458 0.046 DBMET02113 0.503 0.028 DBMET02112 | DBMET02112 | |
| 0.024 | 0.294 | 0.099 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.099 0.011 DBMET02113 | DBMET02113 | |
| 0.03 | 0.302 | 0.089 | Nitric-oxide synthase inhibitor | 0.089 0.08 DBMET02111 | DBMET02111 | |
| 0.014 | 0.285 | 0.048 | Plasmepsin II inhibitor | 0.048 0.019 DBMET02111 | DBMET02111 | |
| 0.029 | 0.3 | 0.061 | Ryanodine receptor antagonist | 0.061 0.034 DBMET02113 | DBMET02113 | |
| 0.02 | 0.294 | 0.059 | Heparanase inhibitor | 0.059 0.025 DBMET02113 0.059 0.024 DBMET02112 | DBMET02112 | |
| 0.03 | 0.306 | 0.144 | Prolactin inhibitor | 0.144 0.025 DBMET02113 | DBMET02113 | |
| 0.005 | 0.281 | 0.04 | Sirtuin 2 inhibitor | 0.04 0.018 DBMET02113 | DBMET02113 | |
| 0.047 | 0.324 | 0.156 | Protein kinase stimulant | 0.156 0.064 DBMET02113 0.146 0.071 DBMET02112 | DBMET02113 | |
| 0.05 | 0.329 | 0.1 | CC chemokine 5 receptor agonist | 0.1 0.021 DBMET02113 | DBMET02113 | |
| 0.017 | 0.296 | 0.148 | Sphingosine 1-phosphate receptor 5 agonist | 0.052 0.041 DBMET02111 0.148 0.005 DBMET02112 | DBMET02112 | |
| 0.009 | 0.29 | 0.069 | Glutamate (mGluR3) antagonist | 0.062 0.008 DBMET02113 0.069 0.006 DBMET02112 | DBMET02112 | |
| 0.002 | 0.284 | 0.012 | Egl nine homolog 3 inhibitor | 0.012 0.009 DBMET02113 | DBMET02113 | |
| 0.009 | 0.291 | 0.058 | CDK5/p25 inhibitor | 0.058 0.016 DBMET02113 | DBMET02113 | |
| 0.028 | 0.31 | 0.116 | Protein kinase C zeta inhibitor | 0.116 0.035 DBMET02113 | DBMET02113 | |
| 0.014 | 0.297 | 0.075 | Amidase inhibitor | 0.075 0.042 DBMET02113 | DBMET02113 | |
| 0.006 | 0.289 | 0.031 | Carnitine palmitoyltransferase 1 inhibitor | 0.031 0.029 DBMET02113 | DBMET02113 | |
| 0.007 | 0.292 | 0.033 | Cholesterol ester transfer protein antagonist | 0.033 0.02 DBMET02112 | DBMET02112 | |
| 0.034 | 0.319 | 0.07 | Transcription factor RelA inhibitor | 0.07 0.03 DBMET02113 | DBMET02113 | |
| 0.018 | 0.303 | 0.144 | Protein kinase (CK2) inhibitor | 0.144 0.036 DBMET02113 | DBMET02113 | |
| 0.018 | 0.306 | 0.051 | Aldosterone antagonist | 0.051 0.028 DBMET02113 | DBMET02113 | |
| 0.067 | 0.355 | 0.203 | CF transmembrane conductance regulator agonist | 0.128 0.124 DBMET02111 0.203 0.02 DBMET02113 0.146 0.083 DBMET02112 | DBMET02113 | |
| 0.009 | 0.297 | 0.047 | Toll-Like receptor 2 agonist | 0.047 0.025 DBMET02111 | DBMET02111 | |
| 0.011 | 0.3 | 0.072 | Liver X receptor alpha agonist | 0.072 0.008 DBMET02113 0.045 0.024 DBMET02112 | DBMET02113 | |
| 0.023 | 0.313 | 0.277 | Potassium channel (Ca-activated) activator | 0.277 0.006 DBMET02113 0.166 0.023 DBMET02112 | DBMET02113 | |
| 0.005 | 0.295 | 0.127 | Estradiol 17 beta-dehydrogenase inhibitor | 0.127 0.008 DBMET02113 | DBMET02113 | |
| 0.03 | 0.322 | 0.099 | Keratolytic | 0.099 0.031 DBMET02113 0.071 0.063 DBMET02112 | DBMET02113 | |
| 0.042 | 0.336 | 0.124 | Antibacterial (Helicobacter pylori) | 0.124 0.075 DBMET02113 | DBMET02113 | |
| 0.001 | 0.295 | 0.006 | Insulin like growth factor 3 antagonist | 0.006 0.005 DBMET02113 | DBMET02113 | |
| 0.005 | 0.3 | 0.048 | AMPA receptor antagonist | 0.048 0.033 DBMET02113 | DBMET02113 | |
| 0.004 | 0.3 | 0.039 | Cathepsin L1 inhibitor | 0.039 0.028 DBMET02111 | DBMET02111 | |
| 0.035 | 0.332 | 0.152 | Cytidine deaminase inhibitor | 0.152 0.074 DBMET02113 | DBMET02113 | |
| 0.012 | 0.311 | 0.051 | Glutamate (mGluR4) agonist | 0.051 0.01 DBMET02113 | DBMET02113 | |
| 0.045 | 0.346 | 0.157 | TRPA1 agonist | 0.157 0.027 DBMET02113 0.11 0.072 DBMET02112 | DBMET02113 | |
| 0.031 | 0.332 | 0.228 | Glutathione S-transferase inhibitor | 0.096 0.041 DBMET02111 0.114 0.026 DBMET02113 0.228 0.004 DBMET02112 | DBMET02112 | |
| 0.02 | 0.323 | 0.075 | Potassium channel intermediate-conductance Ca-activated blocker | 0.075 0.021 DBMET02113 | DBMET02113 | |
| 0.022 | 0.325 | 0.091 | Glutamate (mGluR7) antagonist | 0.091 0.017 DBMET02113 0.07 0.043 DBMET02112 | DBMET02113 | |
| 0.058 | 0.363 | 0.254 | Hepatoprotectant | 0.14 0.12 DBMET02111 0.254 0.042 DBMET02112 | DBMET02112 | |
| 0.06 | 0.368 | 0.132 | DNA repair enzyme inhibitor | 0.132 0.052 DBMET02113 | DBMET02113 | |
| 0.018 | 0.326 | 0.05 | Glutamate (mGluR group III) antagonist | 0.05 0.02 DBMET02113 | DBMET02113 | |
| 0.047 | 0.356 | 0.253 | Interleukin antagonist | 0.253 0.06 DBMET02111 0.215 0.077 DBMET02112 | DBMET02111 | |
| 0.027 | 0.34 | 0.159 | Mucolytic | 0.129 0.046 DBMET02113 0.159 0.028 DBMET02112 | DBMET02112 | |
| 0.007 | 0.32 | 0.048 | Liver X receptor antagonist | 0.048 0.01 DBMET02113 | DBMET02113 | |
| 0.036 | 0.351 | 0.138 | LIM domain kinase 1 inhibitor | 0.138 0.111 DBMET02113 | DBMET02113 | |
| 0.047 | 0.362 | 0.131 | Cyclin-dependent kinase 8 inhibitor | 0.131 0.101 DBMET02113 | DBMET02113 | |
| 0.01 | 0.326 | 0.103 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.103 0.016 DBMET02113 0.079 0.025 DBMET02112 | DBMET02113 | |
| 0.063 | 0.379 | 0.149 | Vanilloid 1 agonist | 0.128 0.069 DBMET02111 0.149 0.039 DBMET02113 0.12 0.087 DBMET02112 | DBMET02113 | |
| 0.064 | 0.381 | 0.149 | Sphingosine 1-phosphate receptor 2 agonist | 0.117 0.06 DBMET02111 0.149 0.026 DBMET02112 | DBMET02112 | |
| 0.049 | 0.366 | 0.155 | Neuropeptide Y1 antagonist | 0.155 0.057 DBMET02111 0.155 0.057 DBMET02113 | DBMET02113 | |
| 0.083 | 0.401 | 0.295 | Neuropeptide Y2 antagonist | 0.295 0.021 DBMET02111 0.256 0.051 DBMET02113 0.224 0.084 DBMET02112 | DBMET02111 | |
| 0.047 | 0.367 | 0.115 | CDK3/cyclin E inhibitor | 0.115 0.062 DBMET02113 | DBMET02113 | |
| 0.008 | 0.329 | 0.058 | Thymidylate synthase inhibitor | 0.058 0.019 DBMET02113 | DBMET02113 | |
| 0.027 | 0.35 | 0.101 | Protein kinase C gamma inhibitor | 0.101 0.074 DBMET02113 | DBMET02113 | |
| 0.024 | 0.347 | 0.114 | Myeloperoxidase inhibitor | 0.087 0.053 DBMET02111 0.114 0.023 DBMET02113 | DBMET02113 | |
| 0.041 | 0.364 | 0.088 | Phosphodiesterase 6D inhibitor | 0.088 0.081 DBMET02113 | DBMET02113 | |
| 0.004 | 0.327 | 0.057 | Sphingosine 1-phosphate receptor 3 agonist | 0.057 0.013 DBMET02112 | DBMET02112 | |
| 0.019 | 0.344 | 0.07 | ErbB-2 antagonist | 0.07 0.059 DBMET02113 | DBMET02113 | |
| 0.013 | 0.338 | 0.098 | Carbonic anhydrase V inhibitor | 0.098 0.028 DBMET02113 | DBMET02113 | |
| 0.064 | 0.389 | 0.313 | Lipoxygenase inhibitor | 0.313 0.065 DBMET02113 0.202 0.138 DBMET02112 | DBMET02113 | |
| 0.109 | 0.435 | 0.275 | Interleukin 2 agonist | 0.244 0.126 DBMET02111 0.247 0.122 DBMET02113 0.275 0.094 DBMET02112 | DBMET02112 | |
| 0.076 | 0.402 | 0.322 | Hypoxia-inducible factor 1 alpha inhibitor | 0.322 0.055 DBMET02113 0.202 0.149 DBMET02112 | DBMET02113 | |
| 0.067 | 0.395 | 0.485 | 12-Lipoxygenase inhibitor | 0.485 0.023 DBMET02113 0.231 0.121 DBMET02112 | DBMET02113 | |
| 0.006 | 0.335 | 0.107 | Aromatase inhibitor | 0.107 0.02 DBMET02113 | DBMET02113 | |
| 0.014 | 0.347 | 0.082 | Glutamate (mGluR group III) agonist | 0.082 0.013 DBMET02113 | DBMET02113 | |
| 0.01 | 0.343 | 0.057 | CC chemokine 2 receptor antagonist | 0.057 0.035 DBMET02113 | DBMET02113 | |
| 0.023 | 0.357 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.061 DBMET02113 | DBMET02113 | |
| 0.059 | 0.394 | 0.162 | MAP kinase 3 inhibitor | 0.162 0.052 DBMET02113 | DBMET02113 | |
| 0.064 | 0.399 | 0.233 | ATPase inhibitor | 0.233 0.018 DBMET02113 0.188 0.049 DBMET02112 | DBMET02113 | |
| 0.022 | 0.358 | 0.119 | Falcipain 3 inhibitor | 0.119 0.054 DBMET02113 | DBMET02113 | |
| 0.013 | 0.35 | 0.041 | AICAR transformylase inhibitor | 0.041 0.035 DBMET02113 | DBMET02113 | |
| 0.009 | 0.349 | 0.058 | Dihydroorotate dehydrogenase inhibitor | 0.058 0.03 DBMET02113 | DBMET02113 | |
| 0.023 | 0.363 | 0.078 | Caspase 7 inhibitor | 0.078 0.067 DBMET02113 | DBMET02113 | |
| 0.006 | 0.347 | 0.041 | Retinoid X alpha receptor agonist | 0.036 0.023 DBMET02113 0.041 0.019 DBMET02112 | DBMET02112 | |
| 0.031 | 0.373 | 0.175 | Xanthine oxidase inhibitor | 0.125 0.045 DBMET02113 0.175 0.026 DBMET02112 | DBMET02112 | |
| 0.027 | 0.369 | 0.315 | Uric acid excretion stimulant | 0.315 0.005 DBMET02113 0.192 0.014 DBMET02112 | DBMET02113 | |
| 0.007 | 0.352 | 0.045 | Nicotinic acid receptor agonist | 0.045 0.017 DBMET02113 | DBMET02113 | |
| 0.006 | 0.353 | 0.077 | Thromboxane A2 antagonist | 0.061 0.028 DBMET02113 0.077 0.016 DBMET02112 | DBMET02112 | |
| 0.009 | 0.357 | 0.104 | Prostaglandin-E synthase inhibitor | 0.104 0.025 DBMET02113 0.099 0.027 DBMET02112 | DBMET02113 | |
| 0.036 | 0.385 | 0.175 | Toll-Like receptor 2 antagonist | 0.117 0.081 DBMET02111 0.175 0.037 DBMET02113 0.152 0.051 DBMET02112 | DBMET02113 | |
| 0.094 | 0.444 | 0.17 | Heat shock protein 70 antagonist | 0.17 0.018 DBMET02113 0.135 0.094 DBMET02112 | DBMET02113 | |
| 0.006 | 0.355 | 0.065 | Carbonic anhydrase VII inhibitor | 0.065 0.017 DBMET02113 | DBMET02113 | |
| 0.025 | 0.376 | 0.062 | Phosphodiesterase 1C inhibitor | 0.062 0.044 DBMET02113 | DBMET02113 | |
| 0.005 | 0.356 | 0.038 | Prostaglandin EP4 antagonist | 0.038 0.011 DBMET02112 | DBMET02112 | |
| 0.028 | 0.38 | 0.059 | Kallikrein 1 inhibitor | 0.059 0.035 DBMET02111 | DBMET02111 | |
| 0.004 | 0.355 | 0.023 | Methionyl aminopeptidase 2 inhibitor | 0.023 0.021 DBMET02113 | DBMET02113 | |
| 0.004 | 0.358 | 0.035 | Endothelin receptor antagonist | 0.035 0.014 DBMET02112 | DBMET02112 | |
| 0.01 | 0.365 | 0.058 | Glucagon-like peptide 1 agonist | 0.058 0.05 DBMET02112 | DBMET02112 | |
| 0.019 | 0.374 | 0.036 | Integrin alpha1beta1 antagonist | 0.036 0.035 DBMET02112 | DBMET02112 | |
| 0.026 | 0.383 | 0.097 | Aminoacyl-tRNA synthetase inhibitor | 0.097 0.049 DBMET02111 0.087 0.064 DBMET02113 0.081 0.075 DBMET02112 | DBMET02111 | |
| 0.051 | 0.411 | 0.405 | Non-steroidal antiinflammatory agent | 0.221 0.057 DBMET02113 0.405 0.013 DBMET02112 | DBMET02112 | |
| 0.071 | 0.432 | 0.286 | Antithrombotic | 0.233 0.14 DBMET02113 0.286 0.098 DBMET02112 | DBMET02112 | |
| 0.029 | 0.39 | 0.279 | Aryl hydrocarbon receptor agonist | 0.279 0.068 DBMET02113 | DBMET02113 | |
| 0.014 | 0.376 | 0.083 | Carbonic anhydrase VA inhibitor | 0.083 0.035 DBMET02113 | DBMET02113 | |
| 0.012 | 0.374 | 0.065 | Thromboxane synthase inhibitor | 0.054 0.038 DBMET02113 0.065 0.021 DBMET02112 | DBMET02112 | |
| 0.017 | 0.38 | 0.121 | Carbonic anhydrase XIII inhibitor | 0.121 0.029 DBMET02113 | DBMET02113 | |
| 0.045 | 0.41 | 0.152 | Thiol protease inhibitor | 0.13 0.095 DBMET02111 0.152 0.067 DBMET02113 0.139 0.082 DBMET02112 | DBMET02113 | |
| 0.025 | 0.389 | 0.059 | Cathepsin E inhibitor | 0.059 0.041 DBMET02111 | DBMET02111 | |
| 0.016 | 0.381 | 0.151 | Expectorant | 0.103 0.066 DBMET02113 0.151 0.035 DBMET02112 | DBMET02112 | |
| 0.003 | 0.369 | 0.045 | Carbonic anhydrase IV inhibitor | 0.045 0.028 DBMET02113 | DBMET02113 | |
| 0.008 | 0.373 | 0.083 | Thromboxane antagonist | 0.064 0.03 DBMET02113 0.083 0.018 DBMET02112 | DBMET02112 | |
| 0.038 | 0.407 | 0.388 | Immunostimulant | 0.388 0.053 DBMET02111 0.277 0.086 DBMET02113 0.288 0.082 DBMET02112 | DBMET02111 | |
| 0.008 | 0.38 | 0.026 | Glutamate (mGluR1) agonist | 0.024 0.019 DBMET02113 0.026 0.015 DBMET02112 | DBMET02112 | |
| 0.055 | 0.429 | 0.411 | Calpain 2 inhibitor | 0.411 0.055 DBMET02111 0.302 0.113 DBMET02113 0.222 0.17 DBMET02112 | DBMET02111 | |
| 0.035 | 0.41 | 0.46 | Aldehyde dehydrogenase inhibitor | 0.107 0.087 DBMET02111 0.242 0.019 DBMET02113 0.46 0.005 DBMET02112 | DBMET02112 | |
| 0.043 | 0.418 | 0.221 | DNA methyltransferase I inhibitor | 0.221 0.059 DBMET02113 | DBMET02113 | |
| 0.024 | 0.403 | 0.143 | Carbonic anhydrase VI inhibitor | 0.143 0.022 DBMET02113 | DBMET02113 | |
| 0.085 | 0.468 | 0.157 | CC chemokine 6 receptor antagonist | 0.157 0.014 DBMET02113 | DBMET02113 | |
| 0.004 | 0.386 | 0.028 | Thyroid hormone alpha antagonist | 0.028 0.005 DBMET02113 | DBMET02113 | |
| 0.01 | 0.393 | 0.064 | p53 inhibitor | 0.035 0.025 DBMET02113 0.064 0.007 DBMET02112 | DBMET02112 | |
| 0.073 | 0.457 | 0.203 | Neurotensin receptor agonist | 0.203 0.033 DBMET02113 0.155 0.09 DBMET02112 | DBMET02113 | |
| 0.035 | 0.423 | 0.23 | Cytokine production inhibitor | 0.23 0.028 DBMET02112 | DBMET02112 | |
| 0.016 | 0.408 | 0.154 | Glycogen synthase kinase-3 alpha inhibitor | 0.154 0.064 DBMET02113 | DBMET02113 | |
| 0.005 | 0.401 | 0.081 | Carbonic anhydrase VB inhibitor | 0.081 0.022 DBMET02113 | DBMET02113 | |
| 0.003 | 0.399 | 0.08 | Estrogen receptor alpha agonist | 0.08 0.012 DBMET02113 | DBMET02113 | |
| 0.005 | 0.401 | 0.045 | Purinergic P2Y antagonist | 0.045 0.031 DBMET02112 | DBMET02112 | |
| 0.005 | 0.403 | 0.054 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.037 0.02 DBMET02113 0.054 0.007 DBMET02112 | DBMET02112 | |
| 0.02 | 0.425 | 0.069 | CD45 antagonist | 0.06 0.021 DBMET02113 0.069 0.016 DBMET02112 | DBMET02112 | |
| 0.066 | 0.471 | 0.251 | Gastrin inhibitor | 0.251 0.078 DBMET02113 0.231 0.104 DBMET02112 | DBMET02113 | |
| 0.02 | 0.428 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.087 0.062 DBMET02113 0.095 0.047 DBMET02112 | DBMET02112 | |
| 0.036 | 0.443 | 0.161 | Farnesoid X receptor antagonist | 0.161 0.042 DBMET02113 | DBMET02113 | |
| 0.006 | 0.415 | 0.045 | RNA-directed RNA polymerase inhibitor | 0.045 0.015 DBMET02113 | DBMET02113 | |
| 0.029 | 0.44 | 0.243 | Phospholipase A2 inhibitor | 0.145 0.08 DBMET02113 0.243 0.025 DBMET02112 | DBMET02112 | |
| 0.023 | 0.433 | 0.109 | Epidermal growth factor receptor kinase inhibitor | 0.109 0.085 DBMET02113 | DBMET02113 | |
| 0.003 | 0.416 | 0.019 | Free fatty acid receptor 1 agonist | 0.019 0.011 DBMET02112 | DBMET02112 | |
| 0.009 | 0.429 | 0.064 | Purinergic P2 antagonist | 0.064 0.044 DBMET02112 | DBMET02112 | |
| 0.072 | 0.492 | 0.344 | Insulysin inhibitor | 0.212 0.14 DBMET02111 0.344 0.036 DBMET02113 0.216 0.133 DBMET02112 | DBMET02113 | |
| 0.017 | 0.439 | 0.109 | Potassium channel activator | 0.109 0.04 DBMET02113 | DBMET02113 | |
| 0.038 | 0.461 | 0.129 | Aurora-C kinase inhibitor | 0.129 0.085 DBMET02111 | DBMET02111 | |
| 0.04 | 0.463 | 0.214 | DNA methylase inhibitor | 0.214 0.071 DBMET02113 0.142 0.125 DBMET02112 | DBMET02113 | |
| 0.004 | 0.43 | 0.032 | Prostaglandin D2 agonist | 0.032 0.019 DBMET02112 | DBMET02112 | |
| 0.008 | 0.433 | 0.046 | Carbonic anhydrase XIV inhibitor | 0.046 0.037 DBMET02113 | DBMET02113 | |
| 0.009 | 0.435 | 0.112 | Monophenol monooxygenase inhibitor | 0.112 0.067 DBMET02113 0.087 0.085 DBMET02112 | DBMET02113 | |
| 0.032 | 0.459 | 0.081 | Interleukin 5 antagonist | 0.081 0.07 DBMET02113 | DBMET02113 | |
| 0.038 | 0.467 | 0.199 | T cell inhibitor | 0.199 0.007 DBMET02112 | DBMET02112 | |
| 0.034 | 0.466 | 0.27 | Calpain inhibitor | 0.27 0.048 DBMET02111 0.212 0.102 DBMET02113 | DBMET02111 | |
| 0.007 | 0.44 | 0.068 | Xanthine dehydrogenase inhibitor | 0.068 0.033 DBMET02113 0.058 0.04 DBMET02112 | DBMET02113 | |
| 0.021 | 0.457 | 0.149 | AMP-activated protein kinase stimulant | 0.149 0.029 DBMET02113 0.127 0.043 DBMET02112 | DBMET02113 | |
| 0.023 | 0.463 | 0.077 | Adenine nucleotide translocase inhibitor | 0.077 0.011 DBMET02113 0.066 0.019 DBMET02112 | DBMET02113 | |
| 0.015 | 0.456 | 0.144 | MAP kinase kinase inhibitor | 0.144 0.055 DBMET02113 | DBMET02113 | |
| 0.044 | 0.486 | 0.091 | Folate antagonist | 0.091 0.084 DBMET02112 | DBMET02112 | |
| 0.022 | 0.466 | 0.199 | MAP kinase kinase 2 inhibitor | 0.166 0.107 DBMET02111 0.199 0.083 DBMET02113 | DBMET02113 | |
| 0.007 | 0.459 | 0.088 | Selectin antagonist | 0.056 0.053 DBMET02111 0.088 0.033 DBMET02112 | DBMET02112 | |
| 0.02 | 0.474 | 0.19 | Alkaline phosphatase inhibitor | 0.19 0.037 DBMET02113 | DBMET02113 | |
| 0.014 | 0.469 | 0.063 | Fatty acid synthase inhibitor | 0.063 0.032 DBMET02113 | DBMET02113 | |
| 0.039 | 0.495 | 0.216 | Hexokinase inhibitor | 0.216 0.027 DBMET02113 0.187 0.043 DBMET02112 | DBMET02113 | |
| 0.003 | 0.459 | 0.037 | HCV NS5B polymerase inhibitor | 0.037 0.017 DBMET02113 | DBMET02113 | |
| 0.008 | 0.465 | 0.298 | Protein-tyrosine phosphatase 1B inhibitor | 0.298 0.011 DBMET02112 | DBMET02112 | |
| 0.016 | 0.473 | 0.102 | Mediator release inhibitor | 0.102 0.068 DBMET02112 | DBMET02112 | |
| 0.005 | 0.464 | 0.613 | Peroxisome proliferator-activated receptor gamma agonist | 0.613 0.003 DBMET02112 | DBMET02112 | |
| 0.06 | 0.52 | 0.186 | Death-associated protein kinase 2 inhibitor | 0.186 0.047 DBMET02111 0.154 0.096 DBMET02113 | DBMET02111 | |
| 0.022 | 0.483 | 0.295 | Pyruvate kinase inhibitor | 0.295 0.049 DBMET02113 0.168 0.101 DBMET02112 | DBMET02113 | |
| 0.024 | 0.488 | 0.26 | Dual specificity phosphatase 3 inhibitor | 0.26 0.037 DBMET02113 0.217 0.052 DBMET02112 | DBMET02113 | |
| 0.026 | 0.491 | 0.379 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.379 0.043 DBMET02113 | DBMET02113 | |
| 0.012 | 0.478 | 0.132 | Alcohol dehydrogenase inhibitor | 0.132 0.028 DBMET02113 0.092 0.062 DBMET02112 | DBMET02113 | |
| 0.028 | 0.494 | 0.116 | DNA polymerase I inhibitor | 0.116 0.072 DBMET02113 0.099 0.087 DBMET02112 | DBMET02113 | |
| 0.005 | 0.472 | 0.055 | Cannabinoid CB2 receptor antagonist | 0.055 0.033 DBMET02113 | DBMET02113 | |
| 0.033 | 0.501 | 0.207 | Transcription factor NF kappa B stimulant | 0.207 0.009 DBMET02111 0.085 0.06 DBMET02112 | DBMET02111 | |
| 0.042 | 0.513 | 0.266 | Transcription factor STAT3 inhibitor | 0.181 0.163 DBMET02111 0.266 0.072 DBMET02113 0.215 0.116 DBMET02112 | DBMET02113 | |
| 0.004 | 0.477 | 0.036 | HMG CoA reductase inhibitor | 0.036 0.021 DBMET02112 | DBMET02112 | |
| 0.035 | 0.525 | 0.149 | Interleukin 4 antagonist | 0.149 0.05 DBMET02113 | DBMET02113 | |
| 0.024 | 0.515 | 0.409 | Dual specificity phosphatase inhibitor | 0.409 0.013 DBMET02113 0.18 0.067 DBMET02112 | DBMET02113 | |
| 0.003 | 0.501 | 0.051 | Carbonic anhydrase II inhibitor | 0.051 0.043 DBMET02113 | DBMET02113 | |
| 0.026 | 0.525 | 0.109 | Toll-Like receptor 4 antagonist | 0.107 0.059 DBMET02111 0.108 0.057 DBMET02113 0.109 0.056 DBMET02112 | DBMET02112 | |
| 0.029 | 0.529 | 0.335 | Alpha-glucosidase inhibitor | 0.335 0.143 DBMET02113 | DBMET02113 | |
| 0.005 | 0.508 | 0.15 | Protein kinase (CK2) alpha inhibitor | 0.15 0.042 DBMET02113 | DBMET02113 | |
| 0.02 | 0.527 | 0.153 | Bone formation stimulant | 0.153 0.057 DBMET02112 | DBMET02112 | |
| 0.014 | 0.526 | 0.268 | M18 aspartyl aminopeptidase inhibitor | 0.268 0.017 DBMET02113 | DBMET02113 | |
| 0.021 | 0.535 | 0.417 | Prostaglandin dehydrogenase inhibitor | 0.417 0.062 DBMET02113 | DBMET02113 | |
| 0.003 | 0.519 | 0.055 | Carbonic anhydrase inhibitor | 0.055 0.051 DBMET02113 | DBMET02113 | |
| 0.015 | 0.533 | 0.095 | GABA receptor agonist | 0.095 0.082 DBMET02113 | DBMET02113 | |
| 0.019 | 0.538 | 0.247 | Potassium channel large-conductance Ca-activated activator | 0.247 0.005 DBMET02113 0.084 0.032 DBMET02112 | DBMET02113 | |
| 0.005 | 0.525 | 0.274 | Peroxisome proliferator-activated receptor delta antagonist | 0.274 0.003 DBMET02112 | DBMET02112 | |
| 0.002 | 0.529 | 0.049 | Carbonic anhydrase IX inhibitor | 0.049 0.044 DBMET02113 | DBMET02113 | |
| 0.011 | 0.544 | 0.051 | Cathepsin D inhibitor | 0.051 0.041 DBMET02111 | DBMET02111 | |
| 0.005 | 0.538 | 0.043 | Liver X receptor agonist | 0.043 0.031 DBMET02113 | DBMET02113 | |
| 0.04 | 0.577 | 0.337 | Transcription factor STAT inhibitor | 0.337 0.039 DBMET02113 0.182 0.165 DBMET02112 | DBMET02113 | |
| 0.011 | 0.55 | 0.048 | Neuropeptide agonist | 0.048 0.044 DBMET02111 | DBMET02111 | |
| 0.009 | 0.549 | 0.106 | Leukotriene synthesis inhibitor | 0.106 0.023 DBMET02113 | DBMET02113 | |
| 0.012 | 0.555 | 0.365 | Protein-tyrosine phosphatase inhibitor | 0.175 0.059 DBMET02113 0.365 0.011 DBMET02112 | DBMET02112 | |
| 0.025 | 0.569 | 0.284 | Antiamyloidogenic | 0.284 0.057 DBMET02113 | DBMET02113 | |
| 0.012 | 0.557 | 0.037 | Glutamate (mGluR8) antagonist | 0.037 0.022 DBMET02112 | DBMET02112 | |
| 0.004 | 0.549 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.015 0.012 DBMET02113 | DBMET02113 | |
| 0.003 | 0.552 | 0.106 | Growth hormone secretagogue receptor agonist | 0.106 0.005 DBMET02111 | DBMET02111 | |
| 0.014 | 0.564 | 0.12 | Caspase 3 inhibitor | 0.12 0.06 DBMET02113 0.102 0.089 DBMET02112 | DBMET02113 | |
| 0.004 | 0.555 | 0.043 | Leukotriene D4 antagonist | 0.043 0.011 DBMET02112 | DBMET02112 | |
| 0.019 | 0.572 | 0.305 | Heat shock protein 90 alpha antagonist | 0.305 0.013 DBMET02113 | DBMET02113 | |
| 0.014 | 0.577 | 0.073 | CXC chemokine 1 receptor antagonist | 0.073 0.011 DBMET02113 | DBMET02113 | |
| 0.005 | 0.572 | 0.071 | Purinergic P2X3 antagonist | 0.037 0.02 DBMET02111 0.071 0.006 DBMET02112 | DBMET02112 | |
| 0.004 | 0.572 | 0.081 | Prostaglandin EP2 antagonist | 0.081 0.026 DBMET02112 | DBMET02112 | |
| 0.012 | 0.581 | 0.105 | Cyclooxygenase 2 inhibitor | 0.105 0.098 DBMET02113 | DBMET02113 | |
| 0.03 | 0.602 | 0.429 | 15-Lipoxygenase inhibitor | 0.429 0.062 DBMET02113 | DBMET02113 | |
| 0.029 | 0.607 | 0.226 | Thyroid hormone beta antagonist | 0.226 0.134 DBMET02113 | DBMET02113 | |
| 0.012 | 0.59 | 0.136 | Src kinase inhibitor | 0.136 0.094 DBMET02113 | DBMET02113 | |
| 0.007 | 0.586 | 0.074 | Neuraminidase (influenza) inhibitor | 0.074 0.03 DBMET02111 | DBMET02111 | |
| 0.027 | 0.611 | 0.241 | Thyroid hormone antagonist | 0.241 0.13 DBMET02113 | DBMET02113 | |
| 0.038 | 0.63 | 0.331 | Toll-Like receptor 7 agonist | 0.331 0.092 DBMET02112 | DBMET02112 | |
| 0.004 | 0.597 | 0.048 | Catechol O-methyltransferase inhibitor | 0.048 0.009 DBMET02113 | DBMET02113 | |
| 0.011 | 0.603 | 0.126 | Prostaglandin F2 alpha antagonist | 0.059 0.048 DBMET02113 0.126 0.006 DBMET02112 | DBMET02112 | |
| 0.007 | 0.603 | 0.122 | 5-Lipoxygenase inhibitor | 0.122 0.049 DBMET02113 | DBMET02113 | |
| 0.024 | 0.622 | 0.184 | Histone deacetylase SIRT1 inhibitor | 0.184 0.038 DBMET02111 | DBMET02111 | |
| 0.018 | 0.617 | 0.273 | Heat shock protein 90 antagonist | 0.273 0.015 DBMET02113 | DBMET02113 | |
| 0.008 | 0.607 | 0.077 | CDC25A inhibitor | 0.077 0.047 DBMET02113 | DBMET02113 | |
| 0.017 | 0.619 | 0.107 | DNA directed RNA polymerase inhibitor | 0.107 0.049 DBMET02113 | DBMET02113 | |
| 0.035 | 0.644 | 0.331 | Toll-Like receptor agonist | 0.331 0.092 DBMET02112 | DBMET02112 | |
| 0.01 | 0.619 | 0.148 | Cyclooxygenase 1 inhibitor | 0.148 0.057 DBMET02113 0.13 0.07 DBMET02112 | DBMET02113 | |
| 0.014 | 0.623 | 0.146 | Cyclooxygenase inhibitor | 0.128 0.089 DBMET02113 0.146 0.073 DBMET02112 | DBMET02112 | |
| 0.006 | 0.615 | 0.101 | HIV-1 reverse transcriptase inhibitor | 0.101 0.03 DBMET02113 | DBMET02113 | |
| 0.002 | 0.612 | 0.072 | Estrogen receptor beta agonist | 0.072 0.016 DBMET02113 | DBMET02113 | |
| 0.04 | 0.651 | 0.107 | Factor V inhibitor | 0.107 0.055 DBMET02111 | DBMET02111 | |
| 0.005 | 0.621 | 0.07 | Neuraminidase inhibitor | 0.07 0.033 DBMET02111 | DBMET02111 | |
| 0.003 | 0.622 | 0.034 | Prostaglandin EP3 antagonist | 0.034 0.018 DBMET02112 | DBMET02112 | |
| 0.011 | 0.64 | 0.052 | Glucose-6-phosphate translocase inhibitor | 0.052 0.036 DBMET02113 | DBMET02113 | |
| 0.005 | 0.636 | 0.119 | c-Src kinase inhibitor | 0.119 0.076 DBMET02113 | DBMET02113 | |
| 0.004 | 0.64 | 0.116 | Estrogen agonist | 0.116 0.014 DBMET02113 | DBMET02113 | |
| 0.019 | 0.657 | 0.129 | Hemostatic | 0.129 0.097 DBMET02113 0.127 0.101 DBMET02112 | DBMET02113 | |
| 0.013 | 0.665 | 0.133 | Histone deacetylase class III inhibitor | 0.133 0.058 DBMET02111 | DBMET02111 | |
| 0.006 | 0.659 | 0.167 | HIV-1 integrase inhibitor | 0.167 0.006 DBMET02113 0.072 0.046 DBMET02112 | DBMET02113 | |
| 0.026 | 0.68 | 0.395 | Immunosuppressant | 0.273 0.132 DBMET02111 0.327 0.099 DBMET02113 0.395 0.065 DBMET02112 | DBMET02112 | |
| 0.017 | 0.676 | 0.251 | DNA directed DNA polymerase inhibitor | 0.251 0.191 DBMET02113 | DBMET02113 | |
| 0.008 | 0.67 | 0.182 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.182 0.052 DBMET02113 | DBMET02113 | |
| 0.005 | 0.67 | 0.051 | Protein kinase C epsilon inhibitor | 0.051 0.04 DBMET02111 | DBMET02111 | |
| 0.003 | 0.669 | 0.046 | Growth hormone releasing factor agonist | 0.046 0.015 DBMET02111 | DBMET02111 | |
| 0.043 | 0.71 | 0.284 | Caspase 3 stimulant | 0.242 0.119 DBMET02113 0.284 0.087 DBMET02112 | DBMET02112 | |
| 0.045 | 0.718 | 0.193 | Catenin beta inhibitor | 0.193 0.038 DBMET02113 0.15 0.105 DBMET02112 | DBMET02113 | |
| 0.014 | 0.689 | 0.242 | DNA polymerase beta inhibitor | 0.242 0.197 DBMET02113 | DBMET02113 | |
| 0.004 | 0.692 | 0.059 | Raf kinase C inhibitor | 0.059 0.043 DBMET02113 | DBMET02113 | |
| 0.008 | 0.71 | 0.108 | Lipid peroxidase inhibitor | 0.108 0.107 DBMET02113 | DBMET02113 | |
| 0.007 | 0.715 | 0.278 | Estrogen receptor beta antagonist | 0.278 0.005 DBMET02113 | DBMET02113 | |
| 0.004 | 0.715 | 0.062 | Aldose reductase inhibitor | 0.062 0.031 DBMET02112 | DBMET02112 | |
| 0.015 | 0.729 | 0.079 | Vanilloid agonist | 0.079 0.074 DBMET02113 | DBMET02113 | |
| 0.009 | 0.727 | 0.187 | Platelet antagonist | 0.187 0.111 DBMET02112 | DBMET02112 | |
| 0.009 | 0.743 | 0.469 | Hypolipemic | 0.469 0.015 DBMET02112 | DBMET02112 | |
| 0.036 | 0.771 | 0.261 | Sodium/bile acid cotransporter inhibitor | 0.261 0.117 DBMET02112 | DBMET02112 | |
| 0.034 | 0.771 | 0.176 | Growth hormone agonist | 0.176 0.07 DBMET02111 | DBMET02111 | |
| 0.039 | 0.775 | 0.144 | Lipocortins synthesis antagonist | 0.144 0.115 DBMET02112 | DBMET02112 | |
| 0.019 | 0.77 | 0.187 | Histone acetyltransferase inhibitor | 0.187 0.09 DBMET02113 | DBMET02113 | |
| 0.015 | 0.767 | 0.058 | DNA helicase inhibitor | 0.053 0.042 DBMET02113 0.058 0.032 DBMET02112 | DBMET02112 | |
| 0.003 | 0.78 | 0.021 | Purinergic P2T antagonist | 0.021 0.015 DBMET02112 | DBMET02112 | |
| 0.018 | 0.802 | 0.277 | MAP kinase 1 inhibitor | 0.277 0.205 DBMET02113 | DBMET02113 | |
| 0.007 | 0.791 | 0.26 | Estrogen antagonist | 0.26 0.008 DBMET02113 | DBMET02113 | |
| 0.03 | 0.815 | 0.185 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.185 0.103 DBMET02111 | DBMET02111 | |
| 0.005 | 0.792 | 0.324 | Mcl-1 antagonist | 0.324 0.019 DBMET02113 0.216 0.048 DBMET02112 | DBMET02113 | |
| 0.003 | 0.791 | 0.101 | Prostaglandin D2 antagonist | 0.101 0.005 DBMET02112 | DBMET02112 | |
| 0.009 | 0.802 | 0.337 | Streptokinase A inhibitor | 0.337 0.066 DBMET02113 | DBMET02113 | |
| 0.006 | 0.807 | 0.152 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.152 0.11 DBMET02111 | DBMET02111 | |
| 0.004 | 0.811 | 0.541 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.541 0.009 DBMET02113 | DBMET02113 | |
| 0.004 | 0.813 | 0.533 | Dyrk kinase inhibitor | 0.533 0.011 DBMET02113 | DBMET02113 | |
| 0.006 | 0.821 | 0.091 | Topoisomerase II alpha inhibitor | 0.091 0.046 DBMET02113 | DBMET02113 | |
| 0.004 | 0.827 | 0.192 | Prostaglandin antagonist | 0.192 0.007 DBMET02112 | DBMET02112 | |
| 0.011 | 0.84 | 0.094 | Thioredoxin inhibitor | 0.094 0.056 DBMET02113 | DBMET02113 | |
| 0.025 | 0.86 | 0.12 | NOS3 expression enhancer | 0.12 0.115 DBMET02113 | DBMET02113 | |
| 0.005 | 0.849 | 0.221 | Free radical scavenger | 0.221 0.083 DBMET02113 | DBMET02113 | |
| 0.005 | 0.855 | 0.25 | Antioxidant | 0.25 0.084 DBMET02113 | DBMET02113 | |
| 0.005 | 0.857 | 0.073 | Cell adhesion molecule inhibitor | 0.073 0.064 DBMET02112 | DBMET02112 | |
| 0.005 | 0.87 | 0.114 | Chelator | 0.114 0.059 DBMET02111 0.109 0.065 DBMET02113 | DBMET02111 | |
| 0.004 | 0.884 | 0.089 | Plasminogen activator inhibitor antagonist | 0.089 0.013 DBMET02112 | DBMET02112 | |
| 0.005 | 0.9 | 0.103 | Cell adhesion inhibitor | 0.103 0.083 DBMET02112 | DBMET02112 | |
| 0.003 | 0.907 | 0.202 | HIV-1 integrase (3'-Processing) inhibitor | 0.202 0.009 DBMET02113 | DBMET02113 | |
| 0.005 | 0.911 | 0.222 | Thrombolytic | 0.123 0.107 DBMET02111 0.222 0.042 DBMET02112 | DBMET02112 | |
| 0.003 | 0.913 | 0.209 | HIV-1 integrase (Strand Transfer) inhibitor | 0.209 0.009 DBMET02113 0.058 0.043 DBMET02112 | DBMET02113 | |
| 0.005 | 0.915 | 0.199 | Amyloid beta precursor protein antagonist | 0.199 0.058 DBMET02113 | DBMET02113 | |
| 0.005 | 0.95 | 0.339 | Immunomodulator | 0.339 0.064 DBMET02111 | DBMET02111 | |
| 0.005 | 0.984 | 0.251 | Apoptosis agonist | 0.251 0.213 DBMET02113 | DBMET02113 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |